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1. Summary 
 
Proteins belonging to the RecQ DNA helicase family are highly conserved from bacteria 
to man and are implicated in removing aberrant DNA structures arising during DNA 
replication and repair to prevent inappropriate DNA recombination events. While E.coli 
and yeast have only one RecQ-type helicase, humans have five of these named 
RECQ1, BLM, WRN, RECQ4 and RECQ5. Inherited defects in the genes encoding for 
BLM, WRN and RECQ4 have been found to give rise to Bloom’s, Werner’s and 
Rothmund-Thomson syndrome, respectively. These severe recessive disorders are 
associated with genomic instability, cancer predisposition and premature aging. 
Association of inherited defects in the RECQ1 and RECQ5 genes with human disease 
has not been reported. However, knockout studies in chicken DT40 cells and in mice 
suggested that these genes function as tumor suppressors through enforcing 
chromosomal stability. A numerous biochemical and cellular studies indicated that the 
multiple RecQ homologues in human cells have non-redundant biological roles. 
However, the exact DNA transactions mediated by these proteins remain elusive.   
The goal of this thesis was to advance our understanding of the cellular functions 
of RECQ5 and WRN helicases. In the first project (Kanagaraj et al., 2006), we explored 
the possible role for RECQ5 in replication fork management. Earlier biochemical studies 
from our group have shown that RECQ5 functions as a 3’-5’ DNA helicase and it has 
also an ability to promote DNA strand annealing. We analyzed the action of RECQ5 on 
various synthetic forked DNA structures containing either heterologous or homologous 
arms. We found that the mode of action of RECQ5 helicase on these structures was 
different as compared to other human RecQ helicases. For example, we found that on 
forked structures with heterologous arms, RECQ5 showed preference for unwinding of 
the lagging-strand arm, whereas BLM and WRN helicases displayed a strong 
preference for unwinding of the parental arm. We also showed that RECQ5 promoted 
strand exchange between homologous arms of a synthetic forked DNA structure in a 
reaction dependent on ATP hydrolysis and that human replication protein A (hRPA) 
stimulated this reaction. Further, we identified a domain located in the non-conserved C-
terminal portion of RECQ5 (a region spanning amino acids 561-651) as being important 
for its ability to unwind the lagging-strand arm of the fork and to promote strand 
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exchange on hRPA-coated forked structures. Our cellular studies revealed that RECQ5 
was associated with the DNA replication factories in S phase nuclei and persisted at the 
sites of stalled replication forks after exposure of cells to UV irradiation and cisplatin. 
Moreover, RECQ5 was found to physically interact with the polymerase processivity 
factor proliferating cell nuclear antigen in vitro and in vivo. Taken together, our findings 
suggested that RECQ5 might be involved in the reactivation of stalled replication forks. 
In contrast to the other human RecQ homologues, RECQ5 exists in at least three 
different isoforms (named RECQ5α,  RECQ5β and RECQ5γ) that result from alternative 
mRNA splicing. Although the RECQ5β isoform has been biochemically well 
characterized, no information was available for the other two isoforms. In the second 
project, we studied the biochemical properties of the two uncharacterized isoforms of 
RECQ5 in collaboration with Dr. Xi’s laboratory (Ren et al., 2008). This work clarified 
the function of the zinc (Zn2+)-binding motif that is present in the RECQ5β protein but not 
in the other two short isoforms. Our initial studies have shown that the short RECQ5 
isoforms, RECQ5α and RECQ5γ, containing all conserved helicase motifs do not 
possess ATPase and DNA unwinding activities. Additional biochemical experiments with 
the RECQ5α protein revealed that this RECQ5 isoform was proficient in DNA strand 
annealing. Surprisingly, a fragment of RECQ5β (1-475 aa) containing an intact Zn2+-
binding motif did not exhibit any strand-annealing activity and was proficient in DNA 
unwinding. Further, our results demonstrated that Zn2+-binding motif of the human 
RECQ5β protein negatively regulates the intrinsic DNA strand-annealing activity of the 
helicase domain and is essential for the ATPase and helicase activities of the enzyme. 
Moreover, quantitative kinetic measurements indicated that the regulatory role of the 
Zn2+-binding motif was achieved by enhancing the DNA binding affinity of the enzyme. 
Taking into consideration that Zn2+-binding motif is highly conserved among RecQ family 
DNA helicases, we believe that the novel intra-molecular regulation of RECQ5 catalytic 
activity mediated by the Zn2+-binding motif (identified in this work) may represent a 
universal regulation mode for all RecQ family helicases. 
  To further explore the biological role of the human RECQ5 helicase, we 
employed a proteomic approach to identify proteins associated with RECQ5 in vivo. 
One of the RECQ5 binding partners we found in this analysis was the 
MRE11/RAD50/NBS1 (MRN) complex, a nuclease that functions in many aspects of 
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DNA metabolism including DNA double-strand breaks (DSBs). Accumulating evidence 
suggest that the MRN nuclease acts as a DSB sensor and activates the ATM-signalling 
pathway. Accordingly, defects in the genes encoding for the components of the MRN 
complex lead to severe DNA damage sensitivity, high genomic instability, shortening of 
telomeres and aberrant meiosis. In the third project (Zheng et al., manuscript to be 
submitted), we investigated the biological significance of the association of RECQ5 
with the MRN complex. We have demonstrated that RECQ5 binds directly to the MRE11 
and NBS1 subunits of the MRN complex. The MRN complex and RECQ5 were found to 
co-localize at sites of stalled DNA replication forks and sites of DNA DSBs. Further, we 
showed that the MRN complex is required for the recruitment of RECQ5 to the sites of 
DNA damage. In addition, our biochemical experiments revealed that RECQ5 negatively 
regulates the MRN complex by attenuating its 3’-5’ exonuclease activity. Collectively, 
these data establish a functional relationship between RECQ5 and the MRN complex in 
the cellular response to DNA damage. 
In the last project, we characterized the interaction between the Werner 
syndrome protein (WRN) and the mismatch-repair (MMR) initiation factors (Saydam et 
al., 2007). The MMR system maintains genomic integrity by correcting DNA replication 
errors and preventing recombination between divergent sequences. Werner syndrome 
(WS) is a severe recessive disorder characterized by premature aging, cancer 
predisposition and genomic instability. The gene mutated in WS encodes a bi-functional 
enzyme called WRN that acts as a 3’-5’ DNA helicase and a 3′-5′ exonuclease, but its 
exact role in DNA metabolism is poorly understood. We found that WRN physically 
interacts with the MMR initiation factors, MutSα (heterodimer of MSH2/MSH6), MutSβ 
(heterodimer of MSH2/MSH3) and MutLα (heterodimer of MLH1/PMS2). Also, we found 
that the helicase activity of WRN on forked DNA structures containing a 3’-single-
stranded arm was strongly stimulated by MutSα or MutSβ, but not by MutLα. Moreover, 
the stimulatory effect of MutSα on WRN-mediated unwinding was enhanced by 
presence of a G/T mismatch in the DNA duplex ahead of the fork. Collectively, these 
data are consistent with results of genetic experiments conducted in yeast suggesting 
that MMR factors act in conjunction with a RecQ-type helicase to reject recombination 
between divergent sequences. 
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2. Zusammenfassung 
 
Proteine, die zur RecQ DNA Helikase Familie gehören, sind hoch konserviert vom 
Bakterium bis hin zum Menschen. RecQ Helikasen werden zum Entfernen von 
ungewöhnlicher DNA Strukturen benötigt, die während der DNA Replikation und 
Reparatur entstehen und verhindern daher eine übermässige DNA Rekombination 
(Bachrati & Hickson, 2003). Während E.coli und Hefe nur eine RecQ Helikase haben, 
gibt es beim Menschen fünf Mitglieder dieser Proteine, nämlich RECQ1, BLM, WRN, 
RECQ4 und RECQ5. Vererbte Defekte im BLM, WRN oder RECQ4 Gen werden in 
Patienten mit Bloom, Werner oder Rothmund-Thomson Syndrom gefunden. Dies sind 
schwere rezessive Erkrankungen, die mit genomischer Instabilität, Krebsprädisposition 
und beschleunigtem Alterungsprozess assoziiert sind. Vererbte Defekte im RECQ1 und 
RECQ5 Gen sind bis jetzt nicht in Verbindung gebracht worden mit Erkrankungen beim 
Menschen. Studien mit aviären DT40 knock-out Zellen und in Mäusen deuten jedoch 
darauf hin, dass diese Gene auch als Tumorsuppressoren agieren und die 
chromosomale Stabilität erhöhen. Eine Anzahl biochemischer und zellulärer Studien 
zeigen auf, dass die mehrfachen RecQ Homologe in der humanen Zelle nicht 
redundante biologische Funktionen haben. Die exakte DNA Transaktion, die von diesen 
Proteinen vermittelt wird, bleibt hingegen ungewiss.   
Das Ziel dieser Dissertation war die zelluläre Funktion der RECQ5 und WRN 
Helikase besser zu definieren. Im ersten Projekt (Kanagaraj et al., 2006), untersuchten 
wir die mögliche Funktion von RECQ5 an der Replikationsgabel. Frühere biochemische 
Studien in unserer Gruppe haben gezeigt, dass RECQ5 eine 3’-5’ DNA Helikase ist und 
das Zusammenlegen von einzelsträngiger DNA beschleunigen kann. Wir analysierten 
die Aktivität von RECQ5 mit verschiedenen synthetischen gabelförmiger DNA 
Strukturen, die entweder heterologe oder homologe Arme hatten. Wir fanden andere 
Aktivitätsmuster bei RECQ5 als bei anderen humanen RecQ Helikasen. Zum Beispiel 
zeigte RECQ5 eine Präferenz den Folgestrang zu entwinden, bei einer gabelförmiger 
Duplex-DNA mit heterologen Armen, während BLM und WRN Helikasen eine strarke 
Präferenz aufwiesen den parentalen Arm zu entwinden. Wir zeigten auch, dass RECQ5 
eine Strangaustausch-Reaktion zwischen den homologen Armen einer synthetischen 
gabelförmigen DNA Struktur katalysiert. Diese Reaktion war abhängig von ATP 
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Hydrolyse und wurde stimuliert durch das humane Replikationsprotein (hRPA). Wir 
identifizierten weiter eine Domäne im nicht konservierten C-terminalen Bereich von 
RECQ5 (umfasst Aminosäuren 561 -651), die wichtig ist für das Entwinden des 
Folgestrangarms und die Strangaustausch-Reaktion an einer gabelförmigen Struktur mit 
gebundenem hRPA. Unsere Zellkulturexperimente zeigten auf, dass RECQ5 mit der 
DNA Replikationsmaschinerie im S-Phasenkern assoziiert ist und nach UV-Exposition 
und Cisplatin-Behandlung an Stellen mit blockierten Replikationsgabeln gebunden 
bleibt. Wir fanden zusätzlich eine direkte Interaktion zwischen RECQ5 und dem 
proliferating cell nuclear antigen, dem Prozessivitätsfaktor der Polymerase, in vitro und 
in vivo. Zusammenfassend deuten unsere Resultate darauf hin, dass RECQ5 an der 
Reaktivierung von blockierten Replikationsgabeln beteiligt sein könnte. 
Im Unterschied zu den anderen humanen RecQ Homologen, existiert RECQ5 in 
mindestens drei Isoformen (nämlich RECQ5α, RECQ5β und RECQ5γ), die durch 
alternatives mRNA Spleissen hervorgehen. Die RECQ5β Isoform ist biochemisch gut  
charakterisiert, über die beiden anderen Isoformen waren hingegen keine Informationen 
vorhanden. In einem zweiten Projekt studierten wir die biochemischen Eigenschaften 
dieser uncharakterisierten RECQ5 Isoformen in Kollaboration mit Dr. Xis Labor (Ren et 
al., 2008). In dieser Arbeit wurde die Funktion des Zink (Zn2+)-Bindungsmotifes 
aufgeklärt, das im RECQ5β Protein vorhanden ist, nicht aber in den beiden kurzen 
Isoformen. Unsere ersten Studien haben gezeigt, dass die kurzen RECQ5 Isoformen 
(RECQ5α und RECQ5γ), die alle konservierten Helikasemotife enthalten, keine ATPase 
und DNA-Entwindungs-Aktivität zeigen. Weitere biochemische Experimente mit 
RECQ5α zeigten, dass dieses Protein das Zusammenlegen von einzelsträngiger DNA 
katalysiert. Dieser Vorgang wurde erstaunlicherweise nicht beschleunigt vom RECQ5β 
Fragment (Aminosäure 1-475), das ein intaktes Zn2+-Bindungsmotif enthält und DNA-
Duplex entwinden kann. Unsere Resultate zeigen auf, dass das Zn2+-Bindungsmotif des 
humanen RECQ5 Proteins die intrinsische Einzelstrangpaarungsaktivität der 
Helikasedomäne negativ reguliert und essentiell für die ATPase und Helikaseaktivität 
des Enzymes ist. Quantitative Kinetikmessungen zeigten weiter, dass die regulatorische 
Funktion des Zn2+-Bindungsmotifes durch Stimulierung der DNA-Bindungsaffinität 
erreicht wird. Da das Zn2+-Bindungsmotif unter RecQ DNA Helikasen hoch konserviert 
ist, glauben wir, dass die hier neu identifizierte intramolekulare Regulation der RECQ5 
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Aktivität durch dieses Motif auch bei andern Mitglieder der RecQ Proteinfamilie 
gefunden werden könnte und es sich hierbei um einen universalen 
Regulationsmechanismus handeln könnte. 
Um die biologische Funktion der humanen RECQ5 Helikase weiter zu 
erforschen, führten wir eine Proteom-Analyse durch, mit dem Ziel Proteine, die in vivo 
mit RECQ5 assoziiert sind zu identifizieren. Ein identifizierter Bindungspartner ist der 
MRE11/RAD50/NBS1 (MRN) Komplex, eine Nuklease, die in den DNA Metabolismus 
involviert ist, unter anderem auch in die Reparatur von DNA Doppelstrangbrüchen 
(DSB). Mehrere Anhaltspunkte weisen darauf hin, dass die MRN Nuklease als DSB-
Sensor funktioniert und den ATM Signalweg aktiviert. Defekte in den Genen, die für die 
Komponente des MRN Komplexes kodieren, führen erwartungsgemäss zu erhöhter 
Empfindlichkeit gegenüber DNA-Schäden, hohe genomische Instabilität, verkürzte 
Telomere und fehlerhafte Meiose. In einem dritten Projekt (Zheng et al., Manuskript 
noch nicht eingereicht) untersuchten wir die biologische Signifikanz von der RECQ5-
MRN Interaktion. Wir konnten demonstrieren, dass RECQ5 die Untereinheiten des MRN 
Komplexes, MRE11 und NBS1, direkt bindet. Der MRN Komplex und RECQ5 konnten 
an Stellen von blockierten DNA Replikationsgabeln und DNA DSB co-lokalisiert werden. 
Wir zeigten weiter, dass der MRN Komplex erforderlich ist, um RECQ5 zu den DNA 
Schäden zu rekrutieren. In unseren biochemischen Experimenten konnten wir 
zusätzlich zeigen, dass RECQ5 den MRN Komplex negativ reguliert, indem die 3’-5’ 
Exonukleaseaktivität des MRN Komplexes abgeschwächt wird. Diese Daten weisen auf 
eine funktionelle Beziehung zwischen RECQ5 und dem MRN Komplex in der zellulären 
Antwort auf DNA Schäden hin.  
In einem letzen Projekt (Saydam et al., 2007) charakterisierten wir die 
Interaktion zwischen dem Werner Syndrom Protein (WRN) und den Mismatch-
Reparatur (MMR) Initiationsfaktoren. Das MMR System trägt zur genomischen Integrität 
bei, indem es DNA Replikationsfehler korrigiert und Rekombination zwischen 
abweichenden Sequenzen verhindert. Werner Syndrom (WS) ist eine schwere 
rezessive Erkrankung, die durch einen beschleunigten Alterungsprozess, 
Krebsprädisposition und genomische Instabilität charakterisiert ist. Das Gen, das im WS 
mutiert ist, kodiert für ein bifunktionelles Enzym WRN, das als 3’-5’ DNA Helikase und 
3’-5’ Exonuklease agiert. Die exakte Funktion von WRN im DNA Metabolismus wird bis 
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jetzt nur unvollständig verstanden. Wir fanden eine direkte Interaktion zwischen WRN 
und den MMR Initiationsfaktoren MutSα (Heterodimer zwischen MSH2/MSH6), MutSβ 
(Heterodimer zwischen MSH2/MSH3) und MutLα (Heterodimer zwischen MLH1/PMS2). 
Wir konnten auch zeigen, dass die Helikaseaktivität von WRN an einer gabelförmigen 
DNA Struktur mit einem 3’-einzelsträngigen Arm stark stimuliert wird durch MutSα oder 
MutSβ, nicht aber durch MutLα. Ausserdem wird der stimulatorische Effekt von MutSα 
auf die WRN Helikaseaktivität durch G/T Mismatch in der DNA Duplex vor der 
Replikationsgabel verstärkt. Insgesamt stimmen diese Daten mit genetischen 
Experimenten in Hefe überein und deuten darauf hin, dass MMR Faktoren gemeinsam 
mit RecQ Helikasen funktionieren, um die Rekombination zwischen abweichenden 
Sequenzen zu verhindern. 
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3. Introduction 
 
3.1. Maintenance of genomic stability and cancer 
Today’s living environment poses continuous threat to our genetic material, i.e. DNA. 
Sources such as ionizing radiations, ultraviolet light from the sun, carcinogenic agents 
used in food materials and cigarette smoke cause alterations of DNA (Wogan et al., 
2004). In addition, cellular DNA is subjected to spontaneous damage that includes loss 
of bases, base modifications and changes in base sequence (Lindahl, 1996). If left 
unrepaired, DNA damage can halt cellular metabolic processes (replication, 
transcription etc.), arrests proliferation and trigger apoptosis (Hoeijmakers et al., 2001). 
Such changes in the cells cause genetic mutations (permanent base changes) in the 
DNA sequence (Niida & Nakanishi, 2006). Indeed, the accumulation of mutations over 
time in critical genes contributes to oncogenesis and aging process (Jackson & Loeb, 
1998). Hence, maintenance of the integrity of the genome is paramount to the survival 
and propagation of a living organism. To that end, cells have evolved complex 
molecular pathways to detect and repair the DNA damage (Hoeijmakers et al., 2001). 
The fact that most of these pathways are conserved through evolution from bacteria to 
human, emphasize the biological importance of these pathways (Kennedy & D’Andrea, 
2006). It had been reported that even the lower organisms contain more than 100 genes 
that are known to be involved in the DNA damage recognition and repair (Kennedy & 
D’Andrea, 2006). In humans, approximately 150 DNA repair genes have been identified 
so far (Wood et al., 2005). 
 The five major pathways of DNA repair are: i) direct repair (Lindahl et al., 1988; 
Goosen & Moolenaar, 2007), ii) nucleotide excision repair (NER) (Costa et al., 2003; 
Reardon & Sancar, 2005; Scharer, 2008), iii) base excision repair (BER) (Fortini et al., 
2003), iv) mismatch repair (MMR) (Kunkel & Erie, 2005; Iyer et al., 2006; Jiricny, 2006) 
and v) recombinational repair (RR) (van Gent et al., 2001; Thompson & Schild, 2002; 
Helleday, 2005). The two common steps involved in correction of different lesions by 
these repair pathways are the following: i) recognition of damaged DNA by cellular 
sensor proteins, and ii) recruitment of other repair enzymes working in a pathway to 
correct the DNA lesion (Zhou & Elledge, 2000). Despite these repair mechanisms, 
sometimes DNA damage may persist. In such cases, cells can make use of specialized 
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DNA polymerases that are able to bypass specific types of DNA damage, a process 
called translesion synthesis (TLS) (Lehmann et al., 2007). Detailed description of 
molecular mechanisms of all these repair pathways are presented in the chapter 3.2.  
  
  
Figure 1. Causes (a) and consequences (b) of DNA damage induced by exogenous and endogenous 
sources. DNA repair pathways that are involved in the repair of specific DNA lesions are also shown in 
(a). Adapted from Hoeijmakers et al., 2001. 
  
Inherited mutations in various DNA repair genes lead to disease as a 
consequence of loss of genome stability and high rate of mutagenesis (Spry et al., 
2007). A variety of cancer prone and/or premature aging syndromes have been linked to 
various loss-of-function mutations in these genes (Heinen et al., 2002; Thoms et al., 
2007) (see Table 1). The systematic study of these rare diseases has helped to a better 
understanding of the genes and proteins involved in the major DNA repair pathways. It 
is now known that defects in specific repair pathways cause syndrome(s) with unique 
and defined clinical characteristics (Lynch et al., 2004) (Table 1). Hence, the knowledge 
of the molecular mechanisms of various DNA repair pathways is essential to provide 
clues about the occurrence of different types of cancer and may help to design a better 
cancer therapy. One group of DNA repair genes that function to guard and maintain 
genomic stability includes RecQ-type helicases (Bachrati & Hickson, 2008). 
Understanding the biological importance of these DNA processing enzymes are the 
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focus of the studies presented in this thesis. More details on helicases and RecQ-type 
helicases are described in the Chapters 3.3. and 3.4.  
Table 1. Human hereditary syndromes with defects in DNA-maintenance systems. Adapted from Neveling 
et al., 2007. 
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3.2. DNA damage and DNA repair pathways 
 
3.2.1. Types of DNA damage 
DNA molecules can be damaged in numerous ways. This includes spontaneous 
damage such as deamination, depurination, oxidation and errors occurring during 
replication (Spry et al., 2007). In addition, radiation and environmental chemicals also 
chemically modify DNA bases (Spry et al., 2007). Further, these modifications result in 
abnormal molecular interactions (hydrogen bonding, etc.) between complementary 
bases of the double-stranded DNA. DNA modifications that occur commonly in the cells 
are listed below (see Figure 2).  
i) Base loss - This kind of damage is created by the breakage of glycosyl bond 
linking DNA bases and sugar-phosphate backbone. As a result, the base is 
released and the strand remains intact (abasic site; see Figure 2B). In 
mammals, it is estimated that several thousand purines and several hundreds 
pyrimidines are spontaneously lost every day (De la Torre et al., 2003). Loss 
of a purine or pyrimidine base creates an apurinic/apyrimidinic (AP) site.  
ii) Base modifications – The functional groups of the bases are somewhat 
unstable. For example, the amino groups of nucleic acid bases can be 
spontaneously converted into keto groups. In particular, uracil is frequently 
generated in the cells by spontaneous deamination of cytosine (Figure 2C). 
The other base changes that occur frequently in the cells are adenine to 
hypoxanthine, guanine to xanthine, and 5-methyl cytosine to thymine 
conversions. In addition, methyl or alkyl groups present in the environmental 
chemicals can be added to nucleotide bases. For example, it has been shown 
that S-adenosylmethionine, the normal biological methyl group donor, reacts 
with DNA to produce alkylated bases like 3-methyladenine (Figure 2D). It is 
estimated that several thousands of these modifications are generated each 
day per mammalian genome (Friedberg, 2003). Also, several hyper-reactive 
oxygen species [generally called Reactive oxygen species (ROS)] that are 
generated as byproducts of normal oxidative DNA metabolism can modify 
DNA bases. The formation of thymine glycol by the oxidation of thymine is the 
best example of oxidative modifications of DNA bases (Figure 2E). Some 
other oxidative modifications that frequently occur in DNA are 8-
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hydroxyguanine, 2,6-diamino-4-hydroxy-5-formamidopyrimidine, 8-
hydroxyadenine, 5-hydroxy uracil and 5-hydroxy-cytosine (Wiseman & 
Halliwell, 1996).  
 
 
Figure 2. Examples of potentially mutagenic DNA lesions. A) Structure of the four bases present in DNA. 
B) Generation of abasic (apurinic) site by nucleotide base loss. C) Spontaneous deamination. D) 
Alkylation of DNA. E) Base modification by oxidative injury, F) Structure of cyclobutane pyrimidine dimer. 
Adapted from Spry et al., 2007. 
 
iii) Photodamage – The double bond between the C5 and C6 atoms of 
pyrimidine ring is sensitive to the UV-B (290-320 nm) or UV-C (100-280 nm) 
light. Upon exposure to UV light, these bonds break leading to abnormal 
covalent interactions between neighbouring pyrimidines that significantly alter 
the 3D structure of the double helical DNA (Hussein, 2005). The majority of 
such DNA lesions that are formed upon UV exposure are cyclobutane dimers 
(Figure 2F) (Daya-Grosjean & Sarasin, 2005). In addition, pyrimidine (6,4)-
pyrimidone photoproducts are also formed in lesser amount (Cleaver & 
Crowley, 2002). 
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iv) Mismatched bases – Such damage to the DNA may occur during normal 
replication due to nucleotide misincorporation by DNA polymerases. 
v) Strand breakage – This kind of damage to the DNA is generated either by the 
action of DNA topoisomerases during normal DNA replication or after 
exposure of cells to ionizing radiation. Strand breakage occuring only on one 
DNA strand is called single-stranded break. Breakage of both strands in the 
same location is referred as double-stranded break.  
vi) DNA crosslinks – DNA crosslinks can be created by bifunctional alkylating 
agents, such as psoralens, that chemically attach to nucleotide bases on both 
strands to form an interstrand crosslinks. DNA damaging agents such as UV 
and ionizing radiation are also capable of generating DNA interstrand cross-
links. 
3.2.2. DNA repair pathways 
Different DNA repair pathways are involved in the repair of different kinds of lesions. A 
simple scheme of DNA repair pathways is presented in Figure 3. 
 
   
Figure 3. A simple scheme of DNA repair by different pathways. MMR – MisMatch Repair, NER – 
Nucleotide Excision Repair, BER – Base Excision Repair, HR – Homologous Recombination, NHEJ – 
Non-Homologous End Joining. Adapted from Hakem, 2008. 
 
3.2.2.1. Direct reversal 
Direct reversal of DNA damage is the simplest mechanism among all DNA repair 
pathways described so far. The best example for the direct reversal pathway is the 
conversion of highly mutagenic alkylation lesion O6-methylguanine (O6-meG) to its 
prototype guanine (Margison & Santibanez-Koref, 2002). The O6-meG adducts are 
formed at lower levels in the cell by reaction of cellular catabolites with the guanine 
residues in the DNA (Sedgwick, 1997). The reversal reaction is catalyzed by enzyme 
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called MGMT (O6-methylguanine DNA methyltransferase). In this direct reversal 
pathway, correction of the lesion occurs by direct transfer of the alkyl group on guanine 
to a cysteine residue in the active site of MGMT. The inactive alkyl-MGMT protein 
formed is then degraded by the ubiquitin proteosome pathway (Srivenugopal et al., 
1996). The crystal structure of human MGMT has been established now and it has 
revealed that an O6-meG residue in DNA is flipped out to access the acceptor cysteine 
residue (Daniels et al., 2004). Also, structural studies revealed that the enzyme contains 
two subdomains that are inactive when separated but regain activity when mixed 
together (Fang et al., 2005).  
                                                           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Left panel: Repair of O6-methylguanine in DNA. See text for details. Adapted from Sedgwick 
et al., 2007. Right panel: Photoreactivation reverses UV-induced DNA damage. See text for details. 
Adapted from Friedberg, 2003. 
 
 UV lesions can be also removed by direct repair. The repair mechanism is 
termed photoreactivation and the enzymes that catalyzed this reaction are called 
photolyases. Photoreactivation was the first DNA repair mechanism discovered 
(Dulbecco, 1949). By using blue light photons as an energy source, photolyases with 
two chromophore cofactors resolve these aberrant structures. Briefly, DNA lesions are 
recognized by a photolyase enzyme, which absorbs light at wavelengths >300nm and 
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facilitates a series of photochemical reactions that help convert the dimerized 
pyrimidines to their native form (Figure 4B).  
3.2.2.2. Base excision repair  
Base excision repair (BER) is a multi-step process that is involved in correcting non-
bulky DNA lesions caused by oxidation, methylation, deamination and/or spontaneous 
loss of the DNA bases (Memisoglu & Samson, 2000). These alterations are highly 
mutagenic and, if left unrepaired, pose a significant threat to genome stability 
(Friedberg, 1995). 
BER has two subpathways namely Long-Patch BER (LP-BER) and Short-Patch 
BER (SP-BER) (Figure 5). In both pathways, the N-glycosidic bond between the 
damaged base and the sugar phosphate backbone of the DNA is cleaved, generating 
an apyrimidinic/apurinic (abasic or AP) site. This reaction is carried out by an enzyme 
called DNA glycosylase. Currently, there are eight DNA glycosylases identified in 
humans that share partially overlapping substrate specificity (Scharer & Jiricny, 2001). 
Sometimes, AP sites are also formed by the spontaneous hydrolysis of the N-
glycosidic bond. In either case, the AP site is subsequently processed by the action of 
AP endonuclease 1 (APE1) that cleaves the phosphodiester backbone 5’ to the AP 
site. As a result, a 3’ hydroxyl group and a transient 5’ abasic deoxyribose phosphate 
(dRP) are formed in the DNA. Removal of the dRP can be accomplished by the action 
of DNA polymerase β (pol β), which adds one nucleotide to the 3’ end of the nick and 
removes the dRP moiety using its associated AP lyase activity (Matsumoto & Kim, 
1995). The nicked DNA strand is finally sealed by the action of DNA ligase. SP-BER 
constitutes approximately 80 - 90% of the BER reaction happen in the cells. 
LP-BER is used when the damaged base is resistant to the AP lyase activity of 
pol β (Matsumoto et al., 1994). Hence, LP-BER results in the replacement of 
approximately 2-10 nucleotides including the damaged base. LP-BER essentially 
utilizes the same factors as SP-BER; e.g. a DNA glycosylase, APE1 and pol β. 
However, unlike SP-BER, LP-BER is a PCNA-dependent pathway, and the 
participation of other DNA polymerases is necessary to add several nucleotides to the 
incised strand, displacing the dRP as part of a flap oligonucleotide (Frosino et al., 
1996). The resulting flap oligonucleotide is excised by the action of Flap endonuclease 
1 (FEN-1), which is followed by sealing the nick in DNA by a DNA ligase.  
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Figure 5. A schematic illustration of BER subpathways for damaged bases and DNA strand breaks.  The 
damaged base is represented as *. Divergent base excision steps converge to common steps for end 
processing, followed by repair DNA synthesis (represented as blue dots) and strand sealing. Other details 
are discussed in the text. Adapted from Hegde et al., 2008.  
 
3.2.2.3. Nucleotide excision repair  
Nucleotide excision repair (NER) is considered to be the most flexible DNA repair 
pathway because of its vast substrate specificity. DNA lesions that are predominantly 
repaired by NER are UV lesions (cyclobutane pyrimidine dimers and 6-4 
photoproducts). Other NER substrates include bulky chemical adducts, DNA intrastrand 
crosslinks, and some forms of oxidative damage. A common feature of all lesions 
recognized by the NER pathway is that they cause a distortion of the DNA helix (Hess et 
al., 1997). 
NER is a stepwise process that requires more than 30 different proteins including 
XPA, XPB, XPC, XPD, XPE, XPF and XPG  (Gillet & Scharer, 2006). The different steps 
involved in this process are: i) damage recognition, ii) local opening of the DNA duplex 
around the lesion, iii) dual incision of the damaged DNA strand, iv) gap repair synthesis 
and v) strand ligation (Batty & Wood, 2000) (Figure 6). There are two distinct 
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subpathways of eukaryotic NER repair: i) global genome NER (GG-NER) and ii) 
transcription coupled NER (TC-NER). GG-NER is a slow random process that is 
responsible for inspecting and correcting the damage that occurs through the entire 
genome (Gillet & Scharer, 2006; Nouspikel, 2008), whereas TC-NER is a highly specific 
and efficient repair machinery that corrects damage only on the actively transcribed 
DNA strands (Fousteri & Mullenders, 2008).  
 
    
Figure 6. Nucleotide excision repair (NER). A simplified model of steps in NER is shown. See the text for 
details.  
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Except for their DNA damage recognition mechanisms, both pathways are identical. In 
GG-NER, the XPC/HHR23B protein complex is responsible for the initial damage 
detection. In contrast, damage recognition during TC-NER does not require XPC, but it 
is rather thought to occur when the transcription machinery is stalled at the site of DNA 
lesion. Hence, the first step in TC-NER is the removal of RNA polymerase complex from 
the stall site. This displacement reaction is followed by the recruitment of NER proteins 
to the damaged DNA. The factors required for the displacement of stalled RNA 
polymerase in eukaryotic cells are not known.  
Further steps of GG-NER and TC-NER are almost the same. Following the 
damage recognition step, XPA and the human single-strand binding protein (hRPA) are 
then recruited to the sites of DNA damage. Next, the XPB and XPD helicases, 
components of the multi-subunit transcription factor TFIIH, unwind the DNA duplex in 
the immediate vicinity of the lesion. Later, the endonucleases XPG and ERCC1/XPF 
cleaves one strand of the DNA 3' and 5' to the damage, respectively, generating an 
approximately 30-mer oligonucleotide containing the lesion. The excised oligonucleotide 
is then displaced to initiate the gap repair synthesis. The gap repair synthesis is 
performed by replicative DNA polymerases pol δ and pol ε along with several replication 
accessory factors. Finally, the nick in the repaired strand is sealed by a DNA ligase, 
thus completing the NER process. 
3.2.2.4. Mismatch repair  
The DNA mismatch repair (MMR) pathway is generally required for the correction of 
replication errors such as base-base mismatches and inserion/deletion loops (IDLs), 
resulting from nucleotide misincorporation and template slippage, respectively. Other 
substrates for the MMR system are the mismatches generated by the spontaneous 
deamination of 5-methylcytosine and heteroduplexes formed following genetic 
recombination. Overall, the MMR process is similar to the other excision repair 
pathways described above (see LP-BER and NER). MMR includes the following 
steps: i) DNA lesion (mismatch or IDL) recognition, ii) excision of the DNA strand 
containing the lesion, iii) correction of the strand by DNA repair synthesis and iv) 
sealing of the nicked strand by re-ligation (Jiricny, 2006; Hsieh & Yamane, 2008) 
(Figure 7).  
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In mammals, MMR pathway is initiated by the recognition of mismatches or IDLs by the 
MSH2-MSH6 (MutSα) and MSH2-MSH3 (MutSβ) heterodimers. MutSα is generally 
involved in the recognition of base-base mismatches and single-base IDLs, whereas, 
larger IDLs are recognized by MutSβ  (Drummond et al., 1995; Palombo et al., 1995; 
Palombo et al., 1996; Genschel et al., 1998). The mismatch bound MutSα or MutSβ 
then recruits another heterodimer MLH1-PMS2 (MutLα). This ternary complex 
undergoes an ATP-driven conformational switch, which converts MutSα/β into a sliding 
clamp that can freely move along DNA (Jiricny, 2006). Clamps that encounter 
Replication Factor C (RFC) bound at the 5’-terminus of a strand break, will displace it 
and load Exonuclease I (Exo1). The activated Exo1 then degrades the DNA strand in 5’-
3’ direction. The formed single-stranded gap is stabilized by binding of hRPA. In this 
way, the mismatch is removed from the DNA strand. The gaps in the DNA are then filled 
by replicative DNA polymerase pol δ along with a bound PCNA molecule. Finally, DNA 
ligase I seals the remaining nick to complete the repair process. 
 
    
 
Figure 7. Overview of eukaryotic MMR. For more details see the text. Adapted from Hsieh & Yamane, 
2008.  
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3.2.2.5. Homologous recombination 
DNA double-strand breaks (DSBs) are the most serious type of DNA damage because 
they pose problems for numerous cellular processes including chromosome 
segregation, replication and transcription. DNA DSBs are caused by a variety of sources 
including ionizing radiation, ROS, mechanical stress on the chromosomes and certain 
genotoxic chemicals such as camptothecin, etoposide, anthracyclins and bleomycin 
(Jackson, 2002). In contrast to other types of DNA damage, DSBs affect both strands of 
the DNA duplex and therefore make it impossible to use the complementary strand as a 
template for repair. Hence, failure to repair these defects can result in chromosomal 
instabilities leading to carcinogenesis and cell death (Hoeijmakers, 2001). To avoid the 
detrimental effects of these DNA lesions, cells have evolved two different pathways of 
DSB repair, homologous recombination (HR) (Figure 8) and non-homologous end 
joining (NHEJ) (Figure 9) (Jackson, 2002). 
HR is an error free DNA repair pathway that corrects DSB defects using a 
mechanism that copies genetic information from a homologous, undamaged DNA 
molecule (Figure 8) (Li & Heyer, 2008). The majority of HR-mediated repair takes place 
in the late S- and G2-phases of the cell cycle (Takata et al., 1998). The RAD52 epistasis 
group of proteins, including RAD50, RAD51, RAD52, RAD54, and MRE11 mediate this 
process (Sonoda et al., 2001). HR can be divided into three stages: i) presynapsis, ii) 
synapsis and iii) postsynapsis (San Filippo et al., 2008; Li & Heyer, 2008). During the 
presynapsis stage, DSBs are recognized and processed to form a 3’-OH ended single 
stranded tail, a process called “end resection” (Figure 10a). The MRE11/RAD50/NBS1 
(MRN) complex that exhibits 3’-5’ exonuclease activity is used for this purpose. The 
action of MRN at the damaged site exposes the 3’ ends on either side of the DSB. In 
synapsis stage, the newly formed ssDNA ends are bound by RAD51 to form a 
nucleoprotein filament. Other proteins including RPA, RAD52, RAD54 and several 
additional RAD51-related proteins serve as accessory factors in filament assembly and 
subsequent RAD51 activities (San Filippo et al., 2008). The RAD51 nucleoprotein 
filament then searches the undamaged DNA on the sister chromatid for a homologous 
repair template. Once the homologous DNA has been identified, the damaged DNA 
strand invades the undamaged DNA duplex in a process referred to as DNA strand 
invasion (Figure 8a). A DNA polymerase then extends the 3' end of the invading strand, 
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and this intermediate structure formed during HR process is termed displacement loop 
(D-loop). Recent evidence suggested that a translesion polymerase (DNA polymerase 
η) is involved in the DNA synthesis reaction of HR process (McIlwraith et al., 2005). In 
the postsynapsis stage, this recombination intermediate is resolved and processed to 
complete the HR-directed repair. 
  
Figure 8. Pathways of DSB repairby HR. Abbreviations used are, SDSA – Synthesis Dependent Strand 
Annealing; DSBR – Double Strand Break Repair; HJ – Holliday Junction. Other details are described in 
the text. Adapted from San Filippo et al., 2008. 
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The postsynapsis stage has at least, three different pathways. Only two of this pathway, 
synthesis-dependent strand annealing (SDSA) and double-strand break repair (DSBR), 
are shown in Figure 8. The other pathway is termed break-induced replication (BIR) (Li 
& Heyer, 2008). In SDSA, the invading strand is dismantled following DNA synthesis 
and annealed with the second end, leading to localized conversion without crossover 
(Figure 8b). In DSBR, both ends of the DSB are engaged, either by independent strand 
invasion or by second end capture, leading to double Holliday junction (DHJ) formation 
(Figure 8c). The resolution of such structure is carried out either by a resolvase 
(resulting in non-crossover or crossover products) or by a dissolution mechanism 
involving Bloom syndrome helicase (BLM) and TOPO IIIα (resulting in non-crossover 
products) (Figure 8C).  
3.2.2.6. Non-homologous end joining 
In contrast to HR, Non-homologous end joining (NHEJ) does not require a homologous 
template for DSB repair and usually is error-prone (Weterings & Chen, 2008) (Figure 9).  
 
    
Figure 9. A model for NHEJ. See text for more details. Adapted from Weterings & Chen, 2008. 
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NHEJ pathway is initiated by binding of the Ku70/Ku80 heterodimeric protein to the free 
DNA ends (Featherstone & Jackson, 1999) (Figure 9A). The DNA-Ku heterodimer 
complex then recruits DNA-dependent protein kinase (DNA-PKcs) to the DNA ends that 
protects the DNA against degradation and premature ligation. Further, the bound DNA-
PKcs tethers the DNA ends (Figure 9B). This is followed by the autophosphorylation of 
DNA-PKcs that facilitate the access of DNA ends by the other NHEJ enzymes (Figure 
9B). Although still unclear, ATM mediated phosphorylation of DNA-PKcs is also reported 
to help the recruitment of other NHEJ enzymes to the damage site. This is followed by 
the ligation of DNA ends. Two kinds of end-joining has been reported depending on the 
nature of DNA ends. If the DNA ends are non-compatible, then the ligation reaction is 
carried out in the classical way, by either filling (DNA polymerases) or resection 
(Artemis) of single-strand overhangs, followed by ligation of blunted ends by XRCC4 
and DNA Ligase IV (Figure 9C & D). In case of the DNA DSBs with partially 
complementary overhangs, ligase IV/XRCC4 and XLF/Cernunnos mediate the joining of 
one single-strand overhang with the opposite DNA end, followed by filling of the gap by 
the DNA polymerases (Figure 9C & D).  
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3.3. Helicases 
 
3.3.1. Classification 
Helicases are molecular motors that utilize the free energy derived from the nucleoside 
triphosphate (NTP) hydrolysis for unwinding DNA or RNA duplex substrates (Singleton 
& Wigley, 2002; Caruthers & Mckay, 2002) (Figure 10). These ubiquitous enzymes are 
found in all kingdoms of life and function in almost all nucleic-acid dependent metabolic 
processes including DNA replication and repair, transcription, translation, ribosome 
synthesis, RNA maturation, splicing and nuclear export processes (Tanner & Linder, 
2001; Wu & Hickson, 2006; Singleton et al., 2007). Helicases are classified based on 
the sequence homology, co-factor requirements, substrate preference, subunit 
structure, directionality and processivity (Singleton & Wigley, 2002; Mackintosh & 
Raney, 2006; Singleton et al., 2007). Initial sequence homology studies have identified 
a series of conserved motifs that are believed to be a unique characteristic of helicases 
(Gorbalenya & Koonin, 1993). More recently, it has become evident that these motifs 
are characteristic of proteins termed translocases that couple NTP hydrolysis to 
directional motion along nucleic acid strands (Erzberger & Berger, 2006; Singleton et 
al., 2007), and helicases are a subgroup of these motor proteins. 
 
 
Figure 10. Schematic of nucleic-acid unwinding by a helicase. Adapted from Vindigni, 2007. 
 
Based on amino acid sequence homology, helicases have been classified into six 
superfamilies (SF1 - SF6) (Singleton et al., 2007) (Figure 11a). Both SF1 and SF2 
superfamilies are the largest and their members contain seven motifs designated I, Ia, 
II, III, IV, V and VI. These motifs are involved in nucleoside triphosphate (NTP) binding 
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and are located at the interface between two RecA-like domains as revealed by crystal 
structures of many SF1 and SF2 enzymes (Singleton et al., 2007). Members of the other 
superfamilies contain a lesser number of motifs (Figure 11a). For example, SF3 and 
SF4 members contain only three and five motifs, respectively (Caruthers & Mckay, 
2002) (see Figure 11a). Additional motifs have been identified recently in SF1 and SF2 
that include TxGx motif (Pause & Sonenberg, 1992), Q-motif (Tanner et al., 2003), motif 
IVa (Korolev et al., 1998) and TRG motif (Mahdi et al., 2003). SF1 and SF2 include both 
DNA and RNA helicases that are involved in a wide variety of cellular processes, 
including DNA replication, recombination and the initiation of translation (Tanner et al., 
2003; Wu & Hickson, 2006). These helicases can unwind nucleic acids in either the 3’-5’ 
(type A enzymes) or the 5’-3’ (type B enzymes) direction (Figure 11b). The directionality 
of helicases is defined by polarity of strand on which the enzyme tracks along the 
nucleic acid substrates (Singleton & Wigley, 2002). The other four superfamilies have 
fewer representatives: SF3 includes helicases identified in the genomes of small DNA 
and RNA viruses (Gorbalenya et al., 1990), SF4 includes replicative helicases from 
bacteria and bacteriophages (Ilyina et al., 1992), SF5 includes the bacterial transcription 
termination factor Rho (Derewenda et al., 2004) and SF6 includes members of the AAA+ 
(ATPases Associated with various cellular Activities) family of ATPase (Erzberger & 
Berger, 2006). While the SF3 – SF6 helicases are hexameric, the SF1 and SF2 
enzymes have mainly been found to be monomeric or dimeric (Singleton et al., 2007). 
3.3.2. Helicase motifs 
Structural studies have revealed that the conserved helicase motifs are closely 
associated in the tertiary structure of the protein and that they may form a large 
functional domain (Hall & Matson, 1999). The organization of helicase motifs and their 
involvement in the catalytic function of SF1 and SF2 helicases are shown in Figure 11C. 
Briefly, Q motif consists of nine-amino acids including an invariant glutamine (Q). In the 
yeast translation-initiation factor eIF4A, this motif has been shown to be involved in ATP 
binding and hydrolysis (Tanner et al., 2003). It has also been hypothesized that the Q 
motif is involved in the recognition of the adenine moiety in ATP (Tanner et al., 2003).  
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a) 
 
 
 
b) 
 
 
  c) 
         
Figure 11. a) Classification of helicases and translocases. The classification is based largely on the work of 
Gorbalenya & Koonin (1993). One representative of each of the six helicase superfamilies is given in parentheses. 
The “core domains” and the positions of the signature motifs therein are shown for each class of helicases. Motifs 
coloured yellow represent universal structural elements in all helicases. The positions of additional motifs are shown 
by black boxes, but in contrast to the core domains, these are specific to each protein. Adapted from Singleton et al., 
2007. b) Characteristics of selected DNA helicases. Adapted from Wu & Hickson, 2006. c) Schematic 
representation of DEAD box helicases. Boxes represent conserved helicase motifs showing consensus sequences by 
single letter amino acid (aa) code (Z = D, E, H, K, R; O = S, T; X = any aa). The numbers between the motifs are the 
typical range of aa residues. The proposed functions of the individual motifs are also indicated. Adapted from Tuteja 
& Tuteja, 2004. 
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Motif I contains the conserved sequence GXGKS/T and is called Walker A box (Walker 
et al., 1982). This motif is essential for ATP binding, and its lysine residue has been 
shown to bind the β and γ phosphates of the ATP molecule and the hydroxyl group of 
serine/threonine residue is involved in the coordination of the magnesium (Mg2+) ion, 
which is required for ATP binding and hydrolysis. Motif Ia has been shown to contribute 
to ssDNA binding (Marintcheva & Weller, 2003). Motif II contains the so-called Walker 
“B” motif (DEAD, DEAH, or DEXH), and the proteins containing this motif are also called 
DEAD-box proteins (Linder et al., 1989). The first two residues (D and E) of these 
sequences are highly conserved and the aspartate (D) residue has been shown to 
interact with the Mg2+ ion (Pause & Sonenberg, 1992). Motif III of SF2 helicase has been 
shown to be involved in the coupling of ATP hydrolysis to DNA unwinding (Pause & 
Sonenberg, 1992; Graves-Woodward et al., 1997). The other SF1 and SF2 motifs are 
proposed to mediate the following functions: motif IV along with motif I (in both SF1 and 
SF2 helicases) have been shown to make direct contacts with the nucleotide in the 
enzyme-ADP binary complexes (Hall & Matson, 1999); motif V and motif Ia of SF2 
family members makes direct contacts with the bound oligonucleotide and interact 
primarily with the sugar-phosphate backbone (Hall & Matson, 1999); motif VI has been 
proposed to be required for the movement of helicase along the DNA substrate (Pause 
& Sonenberg, 1992). More details on the roles of the helicase motifs can be found in 
recent review articles (Caruthers & McKay, 2002; Tuteja & Tuteja, 2004). 
3.3.3. Mechanisms of nucleic acid translocation and unwinding by SF1 and SF2 
helicases 
SF1 and SF2 are the largest and most closely related among the six superfamilies of 
helicases that have been classified to date (Singleton et al., 2007). However, the 
structural and biochemical studies have revealed that there are mechanistic differences 
between the SF1 and SF2 helicases in the nature of contacts between the translocating 
motor and the DNA substrate (Singleton & Wigley, 2002). Structural studies conducted 
with the SF1 helicases, PcrA and Rep, revealed that they bind to the substrate through 
hydrophobic interactions with the bases and thus translocate along ssDNA. In contrast, 
structural data available for SF2 helicases suggest that these enzymes interacts with 
nucleic acids via contacts with the phosphodiester backbone, which would allow the 
helicase motor to translocate on both ssDNA and dsDNA (Singleton & Wigley, 2002). In 
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accordance with the structural data, ATP hydrolysis by SF1 helicases is stimulated only 
by ssDNA (type α), whereas the ATPase activity of SF2 helicases is stimulated by both 
ssDNA (type α) and dsDNA (type β) (Singleton & Wigley, 2002; Singleton et al., 2007). 
 
Figure 12. Models for DNA helicase unwinding and translocation. See text for details. Adapted from 
Tuteja & Tuteja, 2004. 
 
Based on structural and biochemical studies, various models have been 
proposed for the mechanism of translocation and unwinding by SF1 and SF2 helicases. 
Two generally accepted models are the inchworm model and the active rolling model 
(Yarranton & Gefter, 1979; Lohman & Bjornson, 1996; Velankar et al., 1999) (Figure 
12). In the inchworm model, the enzyme is bound to ssDNA and upon binding of ATP, it 
starts to translocate along the DNA strand. Helix destabilization and release of one of 
the ssDNA strands takes place as ATP is hydrolyzed (Yarranton & Gefter, 1979) (see 
Figure 12B). The modified inchworm model has been proposed based on the structural 
studies conducted with the PcrA helicase (SF1 type). This model explains the 
movement of a monomeric helicase along ssDNA (Figure 12C and Figure 13). It has 
been shown that ssDNA is bound to domains 1A and 2A of the protein (Velanker et al., 
1999) (Figure 13). After ATP binding, the cleft between these domains closes. During 
this conformational change in the protein, domain 1A releases its grip on ssDNA and 
slides along it, while domain 2A maintains a tight grip on ssDNA (Figure 13b). Upon 
ATP hydrolysis, the inter-domain cleft opens and DNA passes through domain 2A 
resulting in protein translocation along ssDNA (Figure 13c). 
 37 
 
 
Figure 13. Translocation mechanism of SF1 enzymes. Three different steps associated with the 
translocation process of PcrA are shown (a-c). The top row shows molecular contacts based on crystal 
structures of translocation intermediates. Protein residues are in yellow, and the ssDNA is shown as an 
orange rod, with the bases T12-T17 in cyan. The middle row shows each stage as an analogy with hands 
gripping a rod to show which domains have tight or loose grips on the bound ssDNA. The bottom row 
depicts the structural data in the top row in cartoon form showing the locations of pockets (A-D) on the 
enzyme responsible for binding the nucleotide bases of the bound ssDNA. Adapted from Singleton et al. 
2007. 
 
 The active rolling model requires a dimeric enzyme in which the two subunits 
bind alternatively to ssDNA and dsDNA at the ssDNA/dsDNA junction (Lohman & 
Bjornson, 1996). Initially, both subunits of the dimer are bound to ssDNA. Upon ATP 
binding, one of the subunit releases ssDNA and binds to the duplex region (Figure 12A). 
The helix destabilization and the release of one of the DNA strand take place following 
the hydrolysis of ATP. The best example of active rolling mechanism is DNA unwinding 
by the Rep helicase (SF1 type). In the absence of DNA, the Rep protein exists as a 
monomer. Upon DNA binding, it changes its conformation and forms a homodimer. The 
Rep dimer unwinds DNA by an active rolling mechanism in which the two subunits 
alternate in binding dsDNA and 3’ssDNA at the ssDNA/dsDNA junction. In this model, 
translocation along ssDNA is coupled to ATP binding, whereas ATP hydrolysis drives 
the unwinding of multiple DNA base pairs for each catalytic event (Hsieh et al., 1999; 
Delagoutte & von Hippel, 2002).    
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Recent structural studies on the SF1A helicase, UvrD, suggested that DNA unwinding 
occurs by a combined “wrench-and-inchworm” mechanism (Lee & Yang, 2006). In this 
case, ATP binding (1st step) induces domain closing between 2A and 1A/1B/2B, which 
leads to the separation of the first base pair (-1) at the ds-ss junction (Figure 14). During 
this step, the rearrangement of the +4 nt and exit of the +5 nt prepare the ssDNA for 
translocation. In the second step (after ATP hydrolysis), release of ADP and Pi leads to 
domain opening and ssDNA translocation. These two steps complete the unwinding and 
translocation of 1 bp. 
             
Figure 14. Cartoon presentation of the “Wrench-and-inchworm mechanism” for DNA unwinding. Each 
domain is color-coded: Green – domain 1A; Brown – domain 1B; Violet – domain 2A; Blue – domain 2B. 
The gating helix is highlighted in pink. 
 
3.3.4. Helicase functions 
Helicases are implicated in various nuclear processes ranging from DNA replication to 
ATP-dependent chromatin remodeling (Gorbalenya & Koonin, 1993; Singleton & Wigley, 
2002; Becker & Horz, 2002; von Hippel & Delagoutte, 2003). They have been first 
characterized as nucleic-acid dependent ATPases (Wickner et al., 1974; Richet & 
Kohiyama, 1976; Abdel-Monem et al., 1977). Studies over the past four decades have 
established that helicases are motor proteins that utilize the energy derived from NTP 
hydrolysis to translocate along double or single stranded nucleic acids (Figure 15a). 
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Most of the proteins containing helicase motifs have the ability to catalyze the unwinding 
of duplex nucleic acids (Mackintosh & Raney, 2006; Wu & Hickson, 2006) (Figure 15b). 
The basic unwinding reaction catalyzed by all known DNA helicases is similar. They all 
share the following common biochemical properties: nucleic-acid binding; NTP binding; 
nucleic-acid stimulated hydrolysis of NTP; NTP/dNTP hydrolysis dependent unwinding 
of duplex nucleic acids with specific polarity (Tuteja & Tuteja, 2004).  
 
 
Figure 15. Overview of the helicase functions. (a) Classical motor protein mechanism for the 
movement of a helicase along a single-stranded nucleic acid. The helicase representation used 
can correspond either to a monomeric helicase with two alternatively binding foot domains or to a 
dimeric helicase with alternatively binding subunits (leading and lagging subunits). (b) Helicase 
driven unwinding of double-stranded nucleic acid. (c) Helicase driven displacement of a bound 
protein complex from ssDNA or ssRNA. Adapted from von Hippel, 2004. 
                  
Recent studies have also shown that some helicases can disrupt protein/DNA or 
protein/RNA complexes (Jankowsky et al., 2001; Linder et al., 2001; Krejci et al., 2003; 
Fairman et al., 2004; Flores et al., 2005; Hu et al., 2007; Bugreev et al., 2007) (Figure 
15c). These studies indicated that helicases also carry out functions that have nothing to 
do with opening base pairs. Rather, they are shown to translocate along DNA or RNA to 
remove or rearrange proteins that are bound to their nucleic-acid tracks. In some cases, 
the helicases do so by interacting directly with the target proteins. 
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More specialized function have also been reported for helicases that are governed by 
the presence of additional functional domains in their flanking regions. For instance, 
cooperation of helicase with a nuclease domain (Huang et al., 1998; Komori et al., 
2004), a type IA topoisomerase domain (Déclais et al., 2000) and a strand-annealing 
domain (Bachrati & Hickson, 2008) is common in members of the SF2 superfamily. 
More details on novel functions of the helicases are discussed in the following sections. 
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3.4. RecQ Family of DNA Helicases 
3.4.1. Introduction  
The RecQ family of helicases, belonging to SF2, is one of the most highly conserved 
groups of DNA helicases (Bachrati & Hickson, 2003; Bachrati & Hickson, 2008). While 
bacteria and lower eukaryotes such as yeast have a single RecQ homologue, the 
number of RecQ gene present in higher eukaryotes varies from two to seven (Gangloff 
et al., 1994; Nakayama, 2002; Bachrati & Hickson, 2008) (see Figure 17). To date, at 
least two, four, five and seven RecQ homologues were found in Drosophila, C.elegans, 
mammals and plants, respectively (Kusano et al., 1999; Hartung & Puchta, 2006; 
Hanada & Hickson, 2007; Bachrati & Hickson, 2007). Five RecQ family genes that have 
been identified in humans are designated as RECQ1, BLM (RECQ2), WRN (RECQ3), 
RECQ4 and RECQ5 (Puranam & Blackshear, 1994; Ellis et al., 1995; Yu et al., 1996; 
Kitao et al., 1998; Kitao et al., 1999) (see Figure 17). 
 Clinical and experimental evidences suggested that the RecQ helicases 
contribute to the maintenance of genome stability across various species (Fukuchi et al., 
1989; German, 1993; Gangloff et al., 1994; Hanada et al., 1997; Lindor et al., 2000; 
Siitonen et al., 2003; Van Maldergem et al., 2006). Currently, the intense interest in 
understanding the biology of RecQ helicases is driven largely by their connection with 
human genetic diseases. 
 Defects in at least three (BLM, WRN and RECQ4) of five human RecQ 
homologues are responsible for defined genetic syndromes (Figure 16). Mutations in 
BLM and WRN lead to Bloom’s syndrome and Werner’s syndrome, respectively (Ellis et 
al., 1995; Yu et al., 1996). Mutations in RECQ4 results in at least three different RECQ4 
syndromes namely Rothmund-Thomson syndrome (RTS), RAPADILINO and Baller-
Gerold syndrome (BGS) (Kitao et al., 1999; Siitonen et al., 2003; Van Maldergem et al., 
2006). Indeed, each syndrome exhibits different phenotypes. However, all are 
characterized by an increased predisposition to cancer, which is consistent with 
increased chromosomal aberrations and hypermutability observed in cultured cells 
(Hanada & Hickson, 2007). More details on these syndromes are described in the next 
sections. 
 All the members of the RecQ helicase family contain the conserved set of seven 
helicase-motifs characteristic of SF2 helicases (Bachrati & Hickson, 2003). Apart from 
 42 
the conserved helicase motifs, most of the RecQ family members also contain two other 
conserved domains: the RQC (RecQ C-terminal) and HRDC (Helicase and RNaseD C-
terminal) domains (Liu et al., 1999; Bachrati & Hickson, 2003; Bernstein and Keck, 
2003) (Figure 17). Recent structural studies on the E.coli RecQ helicase revealed that 
the RQC domain is comprised of the Zinc (Zn2+)-binding motif and the Winged-Helix 
(WH) domain (Bernstein et al., 2003). As the name suggests, the Zn2+-binding motif is 
responsible for the binding of Zn2+ metal ion and is shown to be important for the 
stability and the DNA binding ability of many RecQ proteins (Bernstein et al., 2003; 
Janscak et al., 2003; Ren et al., 2008). Whereas, the WH domain serves as a double-
stranded DNA (dsDNA)-binding motif, and also in few RecQ’s, it facilitates their 
interaction with other proteins (Bernstein et al., 2003; Lee et al., 2005). The RQC 
domain along with the conserved helicase motifs constitutes the catalytic core of the 
RecQ enzymes. The HRDC domain in some RecQ helicases has been proposed to 
serve as an auxiliary DNA-binding domain (Liu et al., 1999; Bernstein and Keck, 2003; 
Janscak et al., 2003). Recent evidence also suggested that this domain in BLM confers 
DNA structure specificity to the protein (Wu et al., 2005). 
 
                                                                                                                                                                
Figure 16. Human RecQ syndromes. Various disease symptoms exhibited by different RecQ deficient 
patients are listed below. Adpated from http://radonc.yale.edu/faculty/liu.html    
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Most eukaryotic RecQ family members usually have additional N- and C- terminal 
domains flanking the RecQ core (Figure 17). Earlier studies have revealed that the 
additional regions are required for mediating protein-protein interactions (Bachrati & 
Hickson, 2003). Recent studies revealed that, in some cases, the additional domain 
codes for the specialized function of the RecQ protein (Huang et al., 1998; Shen et al., 
1998; Opresko et al., 2004; Garcia et al., 2004; Sangrithi et al., 2005). More details on 
novel functions of the RecQ helicases are described in the next sections. 
 
 
Figure 17. Scheme of RecQ helicases present in various organisms. The name of each polypeptide is 
indicated on the left. Hs, Mm, Xl, Ce, Dm, Sc and Sp stands for Homo sapiens, Mus musculus, Xenopus 
laevis, Caenorhabditis elegans, Drosophila melanogaster, Saccharomyces cerevisiae and 
Schizosacharomyces pombe, respectively. The length of each protein (in amino acids) is indicated on the 
right. The conserved helicase, RQC and HRDC domains are depicted in red, blue and green respectively. 
The conserved exonuclease domain of WRN and FFA-1 (Xenopus homologue of WRN) is shown in 
yellow. The 27-amino-acid direct repeat of WRN and FFA-1 is indicated by pink triangle. The regions 
marked “NLS” stands for Nuclear Localization Signal of the respective protein. Adapted from Bachrati & 
Hickson, 2003.       
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Numerous enzymatic activities have been reported and characterized for the RecQ 
proteins in vitro (Hanada & Hickson, 2007). They possess a DNA dependent ATPase 
and an ATP dependent 3’ - 5’ DNA helicase activity. They can also mediate the 
annealing of complementary single strands of DNA. RecQ enzymes are proficient in the 
branch migration of Holliday junctions. Also, RecQ helicases have been shown to bind 
and unwind variety of DNA structures that includes DNA replication, recombination and 
repair intermediates such as forked DNA, G4-quadruplex DNA, DNA displacement loops 
(D-loops), DNA containing double Holliday junctions (DHJs) and triplex DNA (Bachrati & 
Hickson, 2003). The preferred substrates for the RecQ helicases are presented in 
Figure 18.  
 
                         
Figure 18. Preferred substrates for the RecQ helicases. A) 3’-tailed duplex, B) bubble substrate, C) 
Forked duplex, D) Holliday junction, E) D-loop, F) G-quadruplex structure. Adapted from Cheok et al., 
2005. 
 
Recent studies have demonstrated that RecQ proteins combine DNA strand-
annealing and helicase activities to promote fork-regression/strand-exchange on model 
replication fork substrates (Machwe et al., 2005; Ralf et al., 2006; Kanagaraj et al., 
2006; Machwe et al., 2006). Also, some RecQ helicases were shown capable of 
displacing proteins from DNA (Hu et al., 2007; Bugreev et al., 2007). 
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3.4.2. The Escherichia coli RecQ 
3.4.2.1. Domain organization and structure 
The Escherichia coli (E. coli) RecQ gene was identified during a screen for mutants 
resistant to thymine starvation (Nakayama et al., 1984). Following this finding, genetic 
mapping and cloning of the RecQ gene was achieved (Nakayama et al., 1984; 
Nakayama et al., 1985). Later, the same group determined the primary structure of 
RecQ from the nucleotide sequence of the cloned gene (Irino et al., 1986; Umezu et al., 
1990) (Figure 19). The E. coli RecQ gene codes for a protein of length of 610 amino 
acids. The E.coli RecQ protein was purified and shown to possess an ATP dependent 3’ 
– 5’ DNA helicase activity (Umezu et al., 1990). 
 
 
Figure 19. Schematic diagram of E.coli RecQ. Adapted from Bernstein & Keck, 2003. 
 
Like most helicases, E.coli RecQ possesses seven conserved motifs namely I, 
Ia, II, III, IV, V and VI (Nakayama, 2005). These motifs are located in a region 
comprised of about 350 amino acids (helicase region). In addition, motif 0 was found to 
be present in E.coli RecQ (Bernstein & Keck, 2003). Besides the helicase region, two 
additional domains, RecQ-Ct and HRDC domain (see previous section for more details), 
that are characteristic of most RecQ helicases are also present in E.coli RecQ 
(Bernstein & Keck 2003) (Figure 19). Limited proteolysis of E.coli RecQ revealed that 
the enzyme has a two-domain structure consisting of a larger domain comprising the 
helicase and RecQ-Ct (RQC) regions and a smaller domain constituted by the HRDC 
region (Bernstein & Keck, 2003). Functional studies have revealed that the large 
domain, although unable to stably bind DNA, is sufficient to exhibit normal levels of the 
ATPase and helicase activities in vitro. Hence, this domain is considered to be the 
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catalytic core of the E.coli RecQ enzyme. Additionally, the removal of the first 20 N-
terminal residues (including a part of motif 0) from E.coli RecQ dramatically decreased 
the helicase and ATPase activities but not the DNA binding ability of the enzyme.  
 
 
Figure 20. Structure of the catalytic core of E.coli RecQ. Subdomains consisting the helicase and RecQ-
Ct regions are shown in yellow and blue ribbons, respectively. Adapted from Bernstein & Keck, 2003. 
 
Structural analysis of the catalytic core of E.coli RecQ has revealed that it consist 
of four subdomains: two subdomains are constituted by the helicase region and two 
other subdomains are formed by the RecQ-Ct region (Bernstein et al., 2003) (Figure 
20). The helicase subdomains form a deep cleft, the walls of which are lined by the 
helicase motifs including motif 0 (Figure 20). The proximal RecQ-Ct subdomain is 
involved in Zinc (Zn2+) binding, whereas the distal RecQ-Ct subdomain adopts a helix-
turn-helix structure called winged helix (WH), known to bind DNA. It has been proposed 
that the cleft between the two RecQ-Ct subdomains could serve as a binding site for 
double-stranded (ds) DNA (Bernstein et al., 2003). More recently, crystal structure of the 
E.coli RecQ HRDC domain was solved (Bernstein & Keck, 2005). The HRDC domain 
adopted a globular fold and was preferentially bound to single-stranded DNA. Further, 
mutational studies of the HRDC domain in the full-length E.coli RecQ revealed that it is 
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important for the structure specific DNA binding ability of the enzyme  (Bernstein & 
Keck, 2005).  
3.4.2.2. Biochemical properties 
An important feature of E.coli RecQ is that it does not require free DNA ends to initiate 
unwinding of the DNA substrate (Harmon & Kowalczykowski, 2001). Also, in 
comparison with other RecQ helicases, the E.coli RecQ protein exhibits a wider 
substrate specificity and a higher processivity. It is able to unwind long partial and blunt 
ended duplexes (Bachrati & Hickson, 2003). Addition of E.coli single-stranded DNA 
binding (SSB) protein to the helicase reaction enhances the DNA unwinding activity of 
E.coli RecQ by increasing both the initial rate and the extent of unwinding (Umezu & 
Nakayama, 1993; Harmon & Kowalczykowski, 2001). Other substrates that are 
unwound by E.coli RecQ in vitro are replication fork-like structures, four-way/three-way 
junctions, D-loops and G-quadruplex structures (Harmon & Kowalczykowski, 2001; Wu 
& Maizels, 2001; Bachrati & Hickson, 2003). Unlike other RecQ helicases, E.coli RecQ 
shows a very poor DNA branch-migration activity (Bachrati & Hickson, 2003). The 
quaternary structure of the functional form of E.coli RecQ is still unclear and 
contradictory reports are available in this regard. Earlier report on the basis of kinetic 
studies suggested that the enzyme exist as an oligomer (Harmon & Kowalczykowski, 
2001). But the gel filtration studies conducted later suggested that the enzyme exists as 
a monomer in solution (Xu et al., 2003).  
 E.coli RecQ together with SSB was shown to promote the joint molecule 
formation by E.coli RecA in vitro, using fully duplexed DNA and supercoiled plasmid 
(Harmon & Kowalczykowski, 1998) (Figure 21). Based on this data, it was proposed that 
E.coli RecQ is involved in the initiation of recombination. The recombination 
intermediates formed in this reaction are also disrupted by the helicase activity of E.coli 
RecQ (Harmon & Kowalczykowski, 1998) (Figure 21). Hence, E.coli RecQ is called anti-
recombinase. Also, in the presence of SSB, E.coli RecQ can unwound covalently closed 
plasmids, generating a substrate for topoisomerase III (Topo III) (Harmon et al., 1999). 
A combination of RecQ, Topo III and SSB has been shown to give rise to several forms 
of fully catenated, covalently closed plasmid multimers (Harmon et al., 1999; Harmon et 
al., 2003). These data demonstrated that the E.coli RecQ helicase may act late in 
recombination together with Topo III. Also, E.coli RecQ specifically binds and unwinds 
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DNA substrates that mimic a stalled replication fork with a gap in the leading strand 
(Hishida et al., 2004) (see Figure 22). 
     
Figure 21. Examples of E.coli RecQ catalyzed reactions. See the text for more details. Adapted from 
Nakayama, 2005 
 
3.4.2.3. Cellular functions 
At the cellular level, E.coli RecQ has been shown to play crucial roles in both DNA 
recombination and DNA replication (Heyer, 2004; Nakayama, 2005; Magner et al., 
2007). Earlier studies revealed that in recBC sbcB cells, E.coli RecQ mutations enhance 
UV sensitivity and decrease the efficiency of conjugational recombination (Nakayama et 
al., 1984). Further these studies showed that in the absence of RecBCD pathway, E.coli 
RecQ catalyzed recombination on DNA substrates that contain gaps and nicks. They do 
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so by participating in the RecF pathway that includes RecA, RecF, RecG, RecJ, RecO, 
RecR and RuvABC proteins. Further, it was shown that the rate of illegitimate 
recombination was enhanced 30 – 300 fold in E.coli RecQ mutants (Hanada et al., 
1997). This anti-recombination function of RecQ now seems to be conserved among 
some eukaryotic RecQ proteins (Gangloff et al., 1994; Hu et al., 2007; Bugreev et al., 
2007) (Figure 22B). A recent study has also shown that E.coli RecQ promotes the net 
accumulation of bimolecular recombination intermediates (BRIs) in vivo, suggesting a 
pro-recombination function for the RecQ proteins (Magner et al., 2007). 
   
  
Figure 22. Proposed roles of E.coli  RecQ DNA helicase in genome maintenance. Details are explained in 
the text. Adapted from Heyer, 2004. 
 
Two different roles of E.coli RecQ helicase had been demonstrated in 
chromosomal replication (Courcelle & Hanawalt, 1999; Courcelle et al., 2003; Chow & 
Courcelle, 2004; Hishida et al., 2004).  First, RecQ can function as a road-block 
remover i.e., the unwinding of secondary structures on the template strand that block 
replication. In agreement with this hypothesis, it has been shown that E.coli RecQ 
allows DNA replication to pass through a hairpin structure on the template strand 
(Cromie et al., 2000). Other replication-blocking structures such as G4 tetraplex DNA 
also serve as good substrates for E.coli RecQ in vitro (Wu & Maizels, 2001). The 
second function of RecQ is the processing of arrested/stalled replication forks. It has 
 50 
been shown in E.coli that when the replication fork is stalled by a blockade, the nascent 
lagging-strand DNA is degraded by the combined action of RecQ helicase and RecJ 
exonuclease (Courcelle & Hanawalt, 1999; Courcelle et al., 2003; Chow & Courcelle, 
2004) (Figure 22A). This process is controlled by other recombination proteins in the 
RecF pathway namely RecFOR proteins. As a result, extended single-stranded regions 
are formed on the lagging strand template that would facilitate the loading of RecA to 
this site in the presence of RecFOR (Chow & Courcelle, 2004). Recent evidence had 
shown that the RecA loading not only provides protection to stalled replication forks but 
also generates the SOS signal (Hishida et al., 2004) (Figure 22D).  
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3.4.3. Sgs1 
3.4.3.1. Discovery 
Sgs1, the sole RecQ helicase in the budding yeast Saccharomyces cerevisiae, was 
identified independently by three different groups. Gangloff et al., first isolated sgs1 in a 
screen for suppressors of the top3 slow growth phenotype (Gangloff et al., 1994). Later, 
Hickson’s group identified the same gene in a yeast two-hybrid screen for interaction 
partners of topoisomerase II (Watt et al., 1995). Also, Lu et al., isolated the sgs1 gene 
based on its genetic interaction with mutations in topoisomerase I (Lu et al., 1996).  
3.4.3.2. Cellular phenotypes of Sgs1 deficiency 
sgs1 mutants showed more than 50% decrease in lifespan compared with wild-type 
cells (Sinclair et al., 1997; Mankouri & Morgan, 2001). sgs1 mutants displayed intra- and 
inter-chromosome hyper-recombination, elevated frequency of sister-chromatid 
exchanges (SCEs), gross chromosomal rearrangements and all types of loss-of-
heterozygosity events (Bachrati & Hickson, 2003; Khakhar et al., 2003; Wu & Hickson, 
2006). They also showed an increased rate of illegitimate recombination (Yamagata et 
al., 1998). Mutations in sgs1 suppresses the severe growth and viability defects of 
top3Δ or rmi1Δ mutants, suggesting that Sgs1 acts upstream of these genes (Wu & 
Hickson, 2006). Double mutants of the sgs1 and the telomerase RNA component (either 
tlc1 or est2) showed an increased rate of telomere shortening, suggesting a role for 
Sgs1 in telomere maintenance (Hickson, 2003). sgs1 null strains were hypersensitive to 
UV light (Miyajima et al., 2000; Mullen et al., 2000), methylmethane sulfonate (MMS) 
(Gangloff et al., 2000; Saffi et al., 2000) and hydroxyurea (HU) (Miyajima et al., 2000). 
3.4.3.3. Domain structure 
The Sgs1 gene encodes a 1447 amino acid protein with a predicted molecular mass of 
164 kDa. Based on its primary structure, Sgs1 protein can be divided into two parts: i) a 
non-conserved N-terminal region and ii) a C-terminal region containing the conserved 
domains of RECQ helicases i.e., helicase motifs, RQC and HRDC domains. The 
primary structure of the protein is similar to the human BLM helicase (see Figure 17). 
3.4.3.4. Biochemical properties 
Noone has been successful in the expression and purification of full-length Sgs1 so far. 
Biochemical studies were performed with a deletion variant of Sgs1 spanning 
aminoacids 400 to 1268 (Sgs1400-1268). Wang group showed that the purified protein 
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displayed an ATP- and dATP-dependent 3’-5’ helicase activity (Bennett et al., 1998). In 
addition, Sgs1 was shown to unwind DNA/RNA heteroduplexes. Later, the same group 
showed that Sgs1 is proficient in binding and unwinding of forked DNA structures, three-
way and four-way junctions (Bennett et al., 1999). Also, Sgs1 was shown to unwind the 
G4-quadruplex structures (Sun et al., 1999; Huber et al., 2002). 
3.4.3.5. Interaction partners and cellular roles 
Sgs1 has been shown to play multiple roles in DNA metabolism (Cobb & Bjergbaek, 
2006). The major interaction partners of Sgs1 are topoisomerases. Sgs1 has been 
shown to physically and genetically interact with all three nuclear topoisomerases: 
topoisomerase I, II and III (Gangloff et al., 1994; Watt et al., 1995; Lu et al., 1996). 
The role of topoisomerase I - Sgs1 complex has not been identified yet. 
Topoisomerase II and Sgs1 have been reported to act together to avoid chromosome 
non-disjunction, suggesting that they are involved in the same pathway for 
chromosome segregation (Watt et al., 1996). Based on the primary structure and 
genetic studies, Sgs1 is considered as the yeast homologue of human BLM helicase, 
and hence it was proposed that Sgs1 in concert with topoisomerase III can dissolve 
double Holliday junctions (DHJs) (Ira et al., 2003). Such activity is important for the 
suppression of crossing-over during DSB repair by homologous recombination (HR). 
Consistent with this, sgs1Δ mutants were shown to accumulate RAD51-dependent X-
shaped molecules during perturbed S-phase (Liberi et al., 2005). Two recent studies 
have identified a third member of the Sgs1-topoisomerase III complex termed 
Rmi1/NCE4 (Chang et al., 2005; Mullen et al., 2005). Functional studies revealed that 
Rmi1 is a structure-specific DNA binding protein with a preference for cruciform 
structures. Based on these evidences, the authors proposed that the DNA binding 
specificity of Rmi1 plays a crucial role in targeting Sgs1-topoisomerase III to 
appropriate DNA structures (Mullen et al., 2005). Recent studies have shown that 
Sgs1 play a crucial function in meiotic HR (Oh et al., 2007). In this report, it has been 
shown that absence of Sgs1 in cells lead to the formation of higher levels of joint 
molecules (JMs) that comprise three and four interconnected duplexes (Figure 23). 
Further, the authors provide direct in vivo evidence suggesting that Sgs1 suppresses 
DHJ formation between sister chromatids. 
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Figure 23. Cartoon representation of ternary JMs formed in sgs1 mutants. Adapted from Oh et al., 2007. 
  
Analysis of DNA replication using DNA combing revealed that in cells lacking 
Sgs1, replication forks progressed more quickly through much of the genome than in 
wild-type cells (Versini et al., 2003). On the basis of this study, it has been proposed 
that Sgs1 protein modulates replication fork progression in the absence of exogenous 
damage. Indeed, Sgs1 exhibited a focal distribution in S phase that coincides with some 
sites of de novo DNA synthesis during S phase (Frei & Gasser, 2000). Moreover, 
chromatin immunoprecipitation (ChIP) experiments revealed that Sgs1 binds to 
unperturbed replication forks (Cobb et al., 2003). Also, Sgs1 was shown to be required 
for the stabilization of arrested replication forks. In cells without Sgs1, polε and other 
factors failed to remain associated with the stalled fork and, as a consequence, the 
reestablishment of replication was impaired (Cohen & Sinclair, 2001; Cobb et al., 2003; 
Bjergbaek et al., 2005). Sgs1 also plays a role in S-phase checkpoint signaling after 
DNA damage that is redundant with Rad24 (Frei & Gasser, 2000). It has been shown 
that rad24 sgs1 double mutants have a severely compromised intra-S-phase checkpoint 
and fail to suppress late-origin firing in the presence of DNA damage. All these data 
suggested that there is a link between the Sgs1 helicase and the DNA replication 
process. 
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3.4.4. RECQ1 
3.4.4.1. RECQ1 gene and phenotypic consequences of its dysfunction 
RECQ1 or RECQL was the first human RecQ helicase to be identified. The cDNA 
encoding human RECQ1 was cloned by two groups independently (Puranam & 
Blackshear, 1994; Seki et al., 1994). It is the shortest human RecQ protein made of 649 
amino acids with a predicted molecular mass of 73 kDa. The RECQ1 gene is located on 
chromosome 12p11-12 (Puranam & Blackshear, 1994; Puranam et al., 1995). This 
chromosomal location has been found to coincide with cytogenetic alterations in 
testicular germ-cell tumors (Suijkerbuijk et al., 1993). Also, RECQ1 is differentially 
upregulated in transformed cells or cells that are actively proliferating (Kawabe et al., 
2000). Interestingly, no genetic disorder has been reported to occur due to mutation in 
RECQ1. But, recent analysis has revealed an association of RECQ1 with a reduced 
survival of pancreatic cancer patients (Li, Frazier et al., 2006; Li, Liu et al., 2006). 
 Knockout studies using chicken DT40 cells have shown that RECQ1 has a role in 
promoting cell viability only in the absence of Bloom syndrome helicase (BLM), 
indicating a back up function (Wang et al., 2003). However, knockout studies in mice 
have shown that both BLM and RECQ1 have non-redundant roles in suppressing 
crossovers (Sharma et al., 2007). Cytogenetic analysis of embryonic fibroblasts from 
RECQ1-deficient mice revealed aneuploidy, spontaneous chromosomal breakage and 
frequent translocation events. These observations suggest that RECQ1 play a vital role 
in the maintenance of genomic stability.   
3.4.4.2. Biochemical properties 
A 73 kDa ATPase, called ATPase Q1 (now identified as RECQ1), was purified 
and shown to exhibit 3’ – 5’ helicase activity (Seki et al., 1994). Analytical 
ultracentrifugation, gel-filtration and dynamic light scattering analysis revealed that the 
purified human RECQ1 protein exist as dimer in the presence or absence of DNA (Cui 
et al., 2003; Cui et al., 2004). Recently, the same group showed that RECQ1 exist in 
two assembly states i.e., higher order oligomers consistent with pentamers or 
hexamers, and smaller oligmers consistent with monomers or dimers (Muzzolini et al., 
2007). Further, they showed that the presence of ssDNA and nucleotide co-factors (ATP 
or ATPγS) favoured the oligomeric form of the protein.  
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RecQ1 alone exhibited a poor helicase activity and it was capable of unwinding only 
short partial duplexes. In the presence of human replication protein A (hRPA), it 
displayed an enhanced processivity and could unwind partial duplexes upto 501 bp long 
(Cui et al., 2004). RecQ1 was also shown to unwind other substrates such as Holliday 
junctions and D-loops (Sharma et al., 2005). Apart from helicase activity, RECQ1 
protein was shown to possess strand-annealing function (Sharma et al., 2005). Also, it 
was shown that RECQ1 oligomeric state is associated with the switch from the DNA 
unwinding to the strand-annealing mode (Muzzolini et al., 2007).  
3.4.4.3. Interaction partners and cellular roles 
RECQ1 is the most abundant RecQ helicase in human cells (Kawabe et al., 2000). 
However, very little is known about its cellular function. The first two interaction partners 
of RECQ1 helicase, Qip1 and Rch1, were identified in a yeast two-hybrid screen for 
proteins that interact with a C-terminal part of RECQ1 (Seki et al., 1997). These proteins 
are homologous to importin-α homologues that are involved in nuclear-cytoplasmic 
transport. Also, RECQ1 was found to interact directly with hRPA and hRPA was shown 
to stimulate the helicase activity of RECQ1 (Cui et al., 2004). Physical and functional 
interaction of RECQ1 with the mismatch-repair proteins MutSα and EXO1 was also 
reported (Doherty et al., 2005). 
 
  
Figure 24. Schematic diagram showing the assembly of piRC complexes containing piRNAs, Piwi and 
RecQ1. Shown here is a genomic region that generates a cluster of piRNAs. The left side of the region 
generates antisense RNA transcripts (blue) and the right side generates sense transcripts (green). An 
RNA polymerase of unknown identity is shown in active transcription. These transcripts are processed 
into 25- to 31- nucleotide piRNAs by an unknown mechanism. piRNAs then associate with Piwi and 
RecQ1 to form piRC complexes. These complexes might regulate the genome at the level of DNA or 
histones, or at a posttranscriptional level. Adapted from Carthew, 2006.   
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RECQ1 deficient cells were shown to be hypersensitive to ionizing radiation and 
exhibited an increased load of DNA damage, suggesting that RECQ1 has a unique 
cellular role in DNA repair (Sharma et al., 2007). More recently, RECQ1 was identified 
as a member of a piRNA protein complex that is important for gene silencing (Lau et al., 
2006) (Figure 24). Also, the mechanistic similarities between piRNA synthesis and DNA 
replication processes (Bateman & Wu, 2007) reveal that RECQ1 and its associated 
DNA replication/repair proteins may function together in piRNA biogenesis (Figure 24). 
Interestingly, QDE-3, the RECQ1 homologue of Neurospora crassa has also been 
implicated in gene silencing (Cogoni & Macino, 1999). More future studies are required 
to find out the exact role of RECQ1 in gene silencing and chromosomal stability 
maintenance.  
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3.4.5. The Bloom syndrome helicase 
3.4.5.1. Bloom syndrome 
Bloom syndrome (BS) is an extremely rare, autosomal, recessive genetic disorder of 
humans (Bloom, 1954). It is caused by the genetic defects in the gene BLM that is 
located on chromosome 15q26.1  (Bachrati & Hickson, 2003). The first incidence of BS 
was reported in 1954 (Bloom, 1954). BS is characterized by stunted growth, 
disproportionately small head and unusual skull/facial configuration. The skin present on 
the nose and cheeks shows erythema and this can become chronic upon exposure to 
sun. BS patients show impaired fertility, learning disabilities, moderate mental deficiency 
and most importantly immune deficiency. Type II diabetes mellitus has also been 
observed in young patients. BS patients also show a very high incidence of cancers of 
most types. Leukaemias predominate in childhood, and lymphomas and carcinomas 
appear during adulthood.  
Most of the BLM mutations found in BS are either nonsense mutations or a 
frameshifts leading to a truncated protein. Approximately, 15% of BS cases are due to 
missense mutations in BLM and these mostly map to exons encoding the helicase 
domain of the enzyme (Sanz et al., 2003) (Figure 25).  
 
  
Figure 25. Cartoon diagram showing the positions of mutation identified in BS patients. Helicase and 
RQC domains are shown in green and orange box, respectively. Adapted from Hickson, 2003. 
 
3.4.5.2. Cellular phenotypes of BLM deficiency 
The hallmark feature of BS cells is the elevated frequency of sister chromatid 
exchanges (SCEs), approximately 10-fold higher as compared to normal cells 
(Chaganti, 1974; German, 1977). Isolated ES cells, lymphocytes, primary or 
immortalized fibroblasts of BLM knockout mice (Chester et al., 1998; Luo et al., 2000) 
and BLM deficient DT40 cells (Wang et al., 2000; Imamura et al., 2002) all show an 
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increase in the frequency of SCEs. In clinics, test for SCEs are even carried now to 
diagnose BS in humans. Moreover, BS cells and BLM deficient fibroblasts were shown 
to accumulate micronuclei at very high rates (Yankiwski et al., 2000). BLM deficient ES 
and DT40 cells show an elevated frequency of gene targeting (Luo et al., 2000; Wang et 
al., 2000; Imamura et al., 2002). Increased loss of heterozygosity was also reported in 
BLM deficient mice (Luo et al., 2000).  
 Increased sensitivity of BLM deficient cells to treatment with ethyl/methyl 
methanesulphonate, mitomycin C, 4-nitroquinoline-1-oxide (4NQO), γ-irradiation, 
radiomimetic drugs, UV radiation, camptothecin (topoisomerase I inhibitor) and hydroxy 
urea (HU; the ribonucleotide reductase inhibitor) has been reported (Bachrati & Hickson, 
2003; Bachrati & Hickson, 2008). Also, BS cells are shown to accumulate abnormal 
sized DNA replication intermediates (Lonn et al., 1990). 
3.4.5.3. Biochemical properties 
The BLM protein contains 1417 amino acids. Size-exclusion chromatography indicated 
that it exists as an oligomer in solution. Electron-microscopy studies showed that BLM 
formed tetrameric and hexameric ring structures (Karow et al., 1999). These results 
were supported further by gel-filtration studies conducted using a recombinant N-
terminal fragment of BLM, BLM1-431, which indicated that this fragment forms oligomers 
(Beresten et al., 1999). 
 BLM can unwind a large variety of DNA structures (Bachrati & Hickson, 2003). 
Preferred DNA substrates for the BLM helicase are Holliday junctions, G4 DNA and D-
loops. BLM is also capable of promoting branch-migration of RecA-generated Holliday 
junction intermediates up to a distance of 2.7 kilobases (Karow et al., 2000). BLM was 
also shown to mediate annealing of complementary single-stranded DNA (Cheok et al., 
2005) and to promote replication fork regression in vitro (Machwe et al., 2005; Ralf et 
al., 2006). A unique biochemical characteristic of BLM is that, in conjunction with TOPO 
IIIα, it is able to resolve double Holliday junctions (DHJs) via a strand passage 
mechanism in a reaction termed DHJ dissolution (Wu & Hickson, 2003) It was also 
shown that the HRDC domain of BLM is important for this dissolution (Wu et al., 2005). 
This finding explained the molecular basis for the elevated rate of SCEs in BS cells. 
More recently, it was shown that BLM is responsible for the disruption of RAD51 
filaments to prevent aberrant recombination (Bugreev eta al., 2007). 
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3.4.5.4. Interaction partners and cellular roles 
BLM interacts physically and functionally with many proteins that play critical roles in the 
maintenance of genomic integrity. BLM has been identified as a component of the 
multienzyme complex, called BASC, that has been partially purifed from human cells. 
BASC contains BRCA1 and several other DNA surveillance proteins including MLH1, 
MSH6, MSH2, RFC (replication factor C), RAD50 and ATM (Wang et al., 2000). BLM 
and BRCA1 have been shown to co-localize in untreated cells to discrete nuclear foci. 
Treatment of cells with HU greatly increases the percentage of BLM and BRCA1 co-
localizing foci (Wang et al., 2000).  
Direct physical interaction between BLM and p53 has also been demonstrated in 
vivo (Yang et al., 2002). It was also shown that p53 inhibits the unwinding of Holliday 
junction by BLM. Physical association of BLM and human RAD51 has been shown in 
vivo and in vitro, and the interacting regions on BLM have been mapped to the N- and 
C-terminal parts of the BLM polypeptide (Wu et al., 2001). Also, MLH1and BLM have 
been demonstrated to interact directly in vitro and in vivo. In addition, both proteins co-
localize in untreated as well as in aphidicolin treated cells (Pedrazzi et al., 2001). BLM 
also interacts physically with human single stranded DNA binding protein  (hRPA) 
through a direct interaction with the 70 kDa subunit of hRPA (Brosh et al., 2000). 
Interaction between BLM and hRPA is required for the hRPA-mediated increase of the 
processivity of the BLM helicase. Also, the direct interaction between BLM and WRN 
(another human RecQ helicase) was identified, and it was shown that BLM inhibits the 
exonuclease activity of WRN (von Kobbe et al., 2002). Telomere proteins TRF1 and 
TRF2 have been shown to co-localize with BLM. This co-localization occurs in telomere-
associated PML bodies. Further, direct interaction between TRF2 and BLM was 
identified in vivo and in vitro (Opresko et al., 2002; Stavropoulos et al., 2002). TRF2 has 
also been found to regulate the helicase activity of BLM in vitro. Also, recently it has 
been found that BLM is present in a complex with five of the known Fanconi Anemia 
(FA) proteins (termed FANC A, C, E, F and G) (Meetei et al., 2003). These data suggest 
that there may be a functional connection between BLM and the FANC proteins.  
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Figure 26. Diagrammatic representation of the putative roles of the BLM-TOPOIIIα-BLAP75/RMI1 (human 
RTR) complex in processing HR intermediates. (a) RAD51 mediated strand invasion and D-loop formation 
is shown. (b) If homologous recombination repair does proceed, a key HR intermediate known as the 
“double Holliday junction” (DHJs) forms. These DHJ intermediates are processed by either the human 
RTR complex or putative HJ resolvases. Cleavage by HJ resolvases gives either a noncrossover or 
crossover products. Alternatively, human RTR complex dissolve the DHJ intermediates without any 
crossing over of genetic material. (c) Branch migrationof individual HJs to create a hemicatenane 
intermediate. (d) Decatenation of the hemicatenane structures. Adaptd from Mankouri & Hickson, 2007. 
 
BLM and TOPO IIIα co-localize to discrete nuclear foci in exponentially growing 
cells (Johnson et al., 2000; Wu et al., 2000). Moreover, it was found that TOPO IIIα is 
not localized correctly in BS cells. Further, the N-terminal 133 residues of BLM are 
necessary for the interaction with TOPO IIIα (Hu et al., 2001). Functional studies using 
BLM and TOPO IIIα revealed that they act together in the dissolution of DHJ 
recombination intermediates to generate predominantly non-crossover products (Wu & 
Hickson, 2003) (Figure 26). Additional functional studies revealed that BLAP75, human 
homologue of yeast RMI1, strongly stimulated the reaction (Wu et al., 2006; Raynard et 
al., 2006) (Figure 26). It is proposed that the branch migration activity of BLM converts 
the DHJs into a hemicatenane. Following this, the TOPO IIIα-BLAP75 complex resolves 
the hemicatenane structure using the ssDNA strand passage activity of TOPO IIIα. In 
this way, DHJ is removed without any crossing over (Figure 26). 
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BLM can also form nuclear foci at sites of DNA replication, indicating a role for BLM at 
damaged DNA replication forks (Sengupta et al., 2003). Further, BS cells show defects 
in DNA replication (Lonn et al., 1990). It was also shown that BLM protein is required for 
correct relocalization of the MRE11/RAD50/NBS1 (MRN) complex after replication fork 
arrest (Franchitto & Pichierri, 2002). More recent studies have shown a role for BLM in 
replication-fork restart and in suppression of origin firing after replicative stress (Davies 
et al., 2007). The authors further showed that these functions required the helicase 
activity of BLM and the threonine residue at the position 99  (Thr 99) of BLM that is 
targeted by stress-activated kinases.   
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3.4.6. The Werner syndrome helicase 
3.4.6.1. Werner syndrome 
Werner syndrome (WS) is a rare autosomal recessive disorder characterized by an 
early onset of many features of aging (Werner, 1904; Epstein et al., 1966; Martin, 1978; 
Goto, 1997). WS patients suffer from bilateral ocular cataracts, type II diabetes mellitus, 
osteoporosis, various forms of arteriosclerosis including atherosclerosis, and 
hypogonadism at a relatively young age. The aged appearance is due to the short 
stature, premature graying and loss of hair, scleroderma-like skin changes, and regional 
atrophy of subcutaneous fat. WS patients have an elevated risk of various cancers 
particularly sarcomas (Goto et al., 1996). The disease frequency is 1-22 cases per 
million of the population worldwide. The frequency is quite high in Japan with an 
estimated frequency of 35 WS patients per million of the Japanese population (Satoh et 
al., 1999). 
 WS is caused by mutations in the WRN gene belonging to RecQ family of DNA 
helicases (Yu et al., 1996). The WRN gene is located in the p11-p12 region of 
chromosome 8 (Matsumoto et al., 1997). 
3.4.6.2. Cellular phenotypes of WRN deficiency 
A hallmark feature of WS cells is that in culture, these cells undergo replicative 
senescence much more rapidly than normal cells. The average lifespan of WS 
fibroblasts in culture is about 27% of that of normal cells, and the population doubling 
time is approximately double compared to that of normal cells (Salk et al., 1981). 
Increased sensitivity to 4-nitroquinoline 1-oxide (4NQO) is another hallmark of the WS 
cells (Prince et al., 1999; Imamura et al., 2002; Poot et al., 2002). WS cells are also 
more sensitive to DNA cross-linking drugs such as mitomycin C, melphalan and 
cisplatin (Poot et al., 2001; Saintigny et al., 2002). Furthermore these cells are sensitive 
to the inhibitor of topoisomerase I, Camptothecin (Lebel & Leder, 1998; Okada et al., 
1998). WS cells also show a slight hypersensitivity to γ-irradiation.  
At the chromosomal level, the genomic instability caused due to defect in WRN 
results in a greater frequency of a variety of chromosomal rearrangements, 
transclocations and inversions, as well as a high frequency of extensive deletions 
(Fukuchi et al., 1999). The spontaneous level of DNA breaks has also been found to be 
higher in WS cells than in wild-type cells (Pichierri et al., 2001).   
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3.4.6.3. Domain structure 
Based on the sequence alignment, it has been found that apart from conserved helicase 
domains in the central region, WRN also contain a nuclease domain that is located in 
the N-terminal part of the protein (Yu et al., 1996; Moser et al., 1997). Like other RecQ 
helicases, WRN also possess RQC (Zn-binding and WH subdomains) and HRDC 
domains (Morozov et al., 1997). Based on the data obtained from E.coli RecQ, it may be 
proposed that the zinc (Zn2+) finger motif of WRN is involved in the regulation of its 
enzymatic activity by modulating DNA binding as well as protein folding of WRN 
helicase (Liu et al., 2004). Structural analysis of the DNA- and protein-binding domain 
(DPBD; which includes the WH motif) of WRN suggests that this domain may play a role 
in guiding the WRN protein to the site of action (Hu et al., 2005). Indeed, the DPBD 
region overlaps with a number of known protein-interacting regions of WRN (Lee et al., 
2005). Based on the structural studies, the HRDC region of WRN was proposed as a 
DNA binding site (Liu et al., 1999). Further, recent data demonstrated that the WRN 
protein accumulates at sites of double-stranded DNA breaks in a manner dependent on 
its HRDC domain (Lan et al., 2005). Biochemical studies demonstrated that substrate-
specific DNA binding of WRN is mediated through the following three domains: N-
terminal, RQC, and HRDC (von Kobbe et al., 2003). 
3.4.6.4. Biochemical properties 
Like other RecQ family members, WRN exhibits ATP dependent 3’ – 5’ DNA helicase 
activity. WRN displayed a strong helicase activity on DNA bubble substrates. WRN is 
able to unwind G-quadruplex DNA, D-loop structures and to branch migrate Holliday 
junctions (Bachrati & Hickson, 2003). In addition to the helicase activity, WRN 
possesses a 3’ – 5’ exonuclease activity (Huang et al., 2000).  The exonuclease domain 
of WRN is located at its N-terminus. WRN can coordinate its helicase and exonuclease 
activities to disrupt D-loop structures in vitro. It has been demonstrated that WRN first 
acts as helicase to unwind the duplex of the invading strand in the D-loop, followed by 
exonucleolytic digestion of unwound DNA strand (Orren et al., 2002). Recently, WRN 
has been shown to possess strand annealing and strand exchange activities (Machwe 
et al., 2005) and the ability to promote fork regression (Machwe et al., 2006).  
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3.4.6.5. Interacting partners and cellular roles 
Numerous proteins have been shown to interact with WRN through its RQC or HRDC 
domains (Cheng & Bohr, 2003; Brosh & Bohr, 2007). Characterizaton of these 
interactions revealed that WRN participates in multiple DNA metabolic pathways (Cheng 
& Bohr, 2003). The WRN protein is involved in DNA double-strand break (DSB) repair 
by nonhomologous end joining (NHEJ) in concert with the DNA-protein kinase complex 
(DNA-protein kinase catalytic subunit, Ku70, and Ku80) (Cooper et al., 2000; Li et al., 
2001; Yannone et al., 2001). Also, a role of WRN in genetic recombination is evident 
from the in vitro and in vivo studies (Prince et al., 2001; Swanson et al., 2004; Cheng et 
al., 2006). Physical and functional association of WRN with flap endonuclease 1 (FEN-
1) (Brosh et al., 2001; Sharma et al., 2005), DNA polymerase β (Harrigan et al., 2003), 
poly (ADP-ribose) polymerase 1 (PARP-1) (Li et al., 2004; von Kobbe et al., 2004), and 
apurinic/apyrimidinic endonuclease 1 (APE1) (Ahn et al., 2004) reveal a role of WRN in 
base excision repair. An involvement of WRN protein in DNA replication is suggested by 
its interaction with DNA topoisomerase I (Laine et al., 2003) and DNA polymerase δ 
(Szekely et al., 2000). Furthermore, the tumor suppressor p53 binds to and inhibits 
WRN exonuclease activity (Brosh et al., 2001). Physical and functional association of 
WRN and RNAPII was also shown and that in the absence of WRN, cells exhibited 
reduced transcription efficiency (Balajee et al., 2001). Physical interaction of telomeric 
repeat binding factor 2 (TRF-2) and WRN protein, in conjunction with biochemical data 
demonstrating the disruption of D-loops by WRN protein, suggests that WRN may 
participate in the maintenance of telomeres (Orren et al., 2002; Opresko et al., 2004). 
WRN protein has been shown to be involved in the lagging strand synthesis at 
telomeres (Crabbe et al., 2004) (Figure 27). In this report, it has been shown that G-
quartet (G4) formation on the lagging telomeric DNA is normally resolved by WRN, 
enabling efficient replication of lagging strand G-rich telomeres. In the absence of WRN, 
G4 formation on the lagging telomere leads to replication fork stalling and deletion of 
lagging-strand telomeres (Crabbe et al., 2004) (Figure 27). The resulting dysfunctional 
telomeres can initiate a p53-dependent DNA-damage response, leading to premature 
onset of replicative senescence. 
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Figure 27. WRN is required for the lagging strand synthesis at telomeres. See text for more details. 
Adapted from Multani & Chang, 2005. 
 
Collectively, WRN protein with two different activities (helicase and exonuclease) 
may be used for various DNA transactions involved in repair, replication, recombination 
and transcription. It is now a challenge to understand how WRN can operate in a 
number of DNA transactions and DNA repair processes.  
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3.4.7. RECQ4 
3.4.7.1. RECQ4 and genetic diseases 
The RECQ4 gene was cloned in 1998 (Kitao et al., 1998). It lies on chromosome 8q24.3 
and encodes a 1208 amino acid protein. Mutations in the RECQ4 gene have been 
found to be associated with three different human disorders namely Rothmund-
Thomson (RTS), RAPADILINO and Baller-Gerold (BGS) syndromes (Kitao et al., 1999; 
Siitonen et al., 2003; Van Maldergem et al., 2006). RTS is an unusual autosomal 
recessive disorder characterized by poikiloderma, growth deficiency, juvenile cataracts, 
premature aging and a predisposition to cancer, particularly osteosarcomas (Rothmund, 
1868; Thomson, 1936; Vennos et al., 1992). Upto 300 RTS cases have been reported 
so far (Vennos et al., 1992; Wang et al., 2001). Interestingly, mutations in the RECQ4 
gene cause only 60% of all RTS cases (Kitao et al., 1999). In most of the cases, the 
mutations result in premature termination of the protein resulting in truncated RECQ4 
that lacks the helicase domain (Lindor et al., 2000). 
 RAPADILINO syndrome was originally described in 14 patients from Finland 
(Siitonen et al., 2003). This name came from the characteristic clinical features exhibited 
by these patients: RAdial hypo-/aplasia, Patellae hypo-/aplasia and cleft or highly 
arched PAlate, DIarrhoea and Dislocated joints, LIttle size and LImb malformation, 
NOse slender and NOrmal intelligence. Also, RAPADILINO patients exhibit 
photosensitivity and growth deficiency. Only 7% of RAPADILINO patients were reported 
to develop cancer (osteosarcomas) (Kellermayer et al., 2005). The most common 
mutations of the RECQ4 gene in RAPADILINO patients represent in-frame deletion of 
exon 7 which do not affect the helicase domain of RECQ4 (Siitonen et al., 2003). 
 BGS was discovered in 1950 (Baller, 1950), and only recently it was found to be 
linked to mutations in the RECQ4 gene (Van Maldergem et al., 2006). 24 cases of BGS 
have been reported to date (Van Maldergem et al., 2006). The clinical hallmarks of BGS 
are radial aplasia/hypoplasia and craniosynostosis. Most mutations of RECQ4 found in 
BGS patients represent an R1021W missense mutation and a 2886 delta T frameshift 
mutaion of exon 9. Surprisingly, none of the 24 BGS patients reported so far showed 
predisposition to cancer (Van Maldergem et al., 2006). 
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3.4.7.2. Cellular phenotypes of RECQ4 deficiency  
Cells derived from RTS patients showed genomic instability, including aneuploidy and 
chromosomal rearrangements (Der Kaloustian et al., 1990; Vennos et al., 1992). 
Additionally, RTS cells are sensitive to ionizing radiation and oxidative damage (Vennos 
& James, 1995; Werner et al., 2006). Three different RECQ4 knockout mice were made. 
Extensive disruption of the RECQ4 gene resulted in embryonic lethality associated with 
severe proliferation defects (Ichikawa et al., 2002). Hoki et al.. generated another 
RECQ4-knockout mouse by deleting exon 13 of the RECQ4 gene that encodes for a 
part of the helicase domain (Hoki et al., 2003). This mouse showed severe growth 
retardation and several tissue abnormalities that resemble defects observed in RTS 
patients. Only 5% of the mutant mice survived the first 14 days, and these mice failed to 
develop tumors. Further, cells derived from mutant mice showed a decreased 
proliferation rate. 
  
  
Figure 28. RECQ4 deficient mice with RTS phenotypes. Photographs of the tails of a wild-type (A) and a 
RECQ4 deficient  (B) mouse. Pigmented areas on the tail is obvious in RECQ4 deficient mouse. Images 
D and F show the radial ray defects in RECQ4 deficient mice. Images C and E are from the wild-type 
mice that show no radial ray defects. Images G-J are the Palatal photographs of the wild-type (G & I) and 
RECQ4 deficient (H & J) mouse. RECQ4 deficient mouse show severe cleft palate (indicated by arrow) 
and patterning defect in the palate (indicated by circle). Adapted from Mann et al., 2005. 
    
The third RECQ4 knockout mouse carried deletion of exons 9-13 removing the 
entire helicase domain (Mann et al., 2005). More than 80% of these mice survived to 
adulthood, with some exhibiting typical clinical features of RTS including pigmented 
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skin, skeletal limb defects and palatal patterning defects (Figure 28). Furthermore, 
chromosomal analysis using different cell types derived from the RECQ4-deficient mice 
displayed aneuploidy and a significant increase in the frequency of premature 
centromere separation.  
3.4.7.3. Domain structure 
The helicase domain of the RECQ4 is located in the central region of the protein. The 
additional regions present at the N- and C-termini of RECQ4 do not show any sequence 
similarity with other RecQ family members (Bachrati & Hickson, 2003). RECQ4 does not 
contain RQC and HRDC domains that are present in other RecQ helicases downstream 
of the helicase domain. The C-terminal region of RECQ4 contains a stretch of acidic 
amino acids (Bachrati & Hickson, 2003). In addition, the N-terminal region of RECQ4 
bears a portion that shows sequence homology to the yeast proteins Sld2 and DRC1 
(Sangrithi et al., 2005). For further details, see the text below.   
3.4.7.4. Biochemical properties 
Very little is known about the biochemical properties of the RECQ4 protein. The first 
biochemical study of RECQ4 was performed using immunoprecipitated RECQ4 protein 
from HeLa cell extracts (Yin et al., 2004). Later, full-length RECQ4 was expressed and 
purified from E.coli (Macris et al., 2006). Both studies showed that RECQ4 exhibits a 
DNA-dependent ATPase activity, but not the DNA unwinding function. In addition, 
Macris et al., showed that RECQ4 binds preferentially to ssDNA and promotes strand 
annealing (Macris et al., 2006). 
3.4.7.5. Interaction partners and cellular roles 
Initial attempts to identify proteins that associate with RECQ4 have revealed that 
RECQ4 exists in a complex with UBR1 and UBR2 that belong to the family of E3 
ubiquitin ligases acting in the N-end rule pathway (Yin et al., 2004). Surprisingly, 
RECQ4 was not found to be ubiquitylated in vivo, and the function of the direct 
interaction between RECQ4 and UBR1/UBR2 still remains unclear. Also, RECQ4 is 
found in a complex with RAD51 in vivo (Petkovic et al., 2005). Further, it was found that 
a fraction of RECQ4 and RAD51 nuclear foci colocalized after the treatment of cells with 
the DSB inducing agent etoposide, suggesting that RECQ4 plays a role in the repair of 
DSBs by homologous recombination. Recently, Cut5 was shown to interact with the 
Xenopus laevis homologue of RECQ4 both in vitro and in vivo (Matsuno et al., 2006). 
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The yeast homologue of Cut5, named Dpb11, was shown to be required for loading 
DNA polymerases onto chromatin (Van Hatten et al., 2002; Hashimoto et al., 2003). 
Also, the N-terminus of RECQ4 has similarity to Sld2 (synthetically lethal with dpb11) 
that is found to interact with Dpb11 (Kamimura et al., 1998; Sangrithi et al., 2005). Thus, 
these findings provide evidence that RECQ4 participates in DNA replication. Also, 
physical association between RECQ4 and poly (ADP-ribose) polymerase-1 (PARP-1) 
has been reported (Woo et al., 2006). Additionally, PARP-1 was shown to modify i.e., 
poly ADP-ribosylate RECQ4 in vitro. 
 Analysis of RECQ4 homologue in Xenopus laevis (xRTS) has indicated a new 
role for RECQ4 in the initiation of DNA replication (Sangrithi et al., 2005). This report 
showed that depletion of RECQ4 in Xenopus laevis egg extracts leads to a reduction 
and delay of sperm chromatin replication. Also, it was showed that this effect was 
rescued by supplementing the extracts with purified human RECQ4 protein. Another 
recent publication showed that purified N-terminal fragments of xRTS were able to 
rescue the DNA replication activity of RECQ4-depleted Xenopus laevis egg extracts 
(Matsuno et al., 2006). Also, knocking down the murine homologue of RECQ4 in 
cultured cells revealed that the rate of DNA replication was highly affected. Further, 
these works showed that xRTS is important for the loading of RPA at the replication site 
(Sangrithi et al., 2005), and also for the chromatin binding of DNA polymerase in the 
initiation of DNA replication (Matsuno et al., 2006). Taken together, these findings 
suggest that RECQ4 functions after pre-replication complex (pre-RC) assembly to make 
origins of replication accessible for loading of subsequent replication factors, which is 
the early step in the initiation of eukaryotic DNA replication (Figure 29). 
 Collectivelly, the published data indicate that RECQ4 is involved in DNA 
replication and repair processes, and further functional studies are needed to 
characterize in more detail the exact role of RECQ4 in these processes.
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Figure 29. Proposed model for the function of RECQ4 (here xRTS) during replication initiation. Other 
details are described in the text. Adapted from Sangrithi et al., 2005. 
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3.4.8. RECQ5 
3.4.8.1. Cloning 
The RECQ5 gene has been mapped to chromosome position 17q25 and cloned by 
Kitao and his colleagues in 1998 (Kitao et al., 1998). Loss of heterozygosity in this 
region has been found to be associated with ovarian cancers and familial breast 
carcinomas (Sekelsky et al., 1999). No human genetic disease has been found to be 
associated thus far with a deficiency in the RECQ5 gene. 
3.4.8.2. Cellular phenotypes of RECQ5 deficiency 
Recent studies using chicken DT40 cells and knockout mice suggested that RECQ5 is 
important for the maintenance of chromosomal stability (Wang et al., 2003; Hu et al., 
2005; Hu et al., 2007). RECQ5 deficiency in DT40 cells does not result in genomic 
instability (Imamura et al., 2002; Wang et al., 2003). However, DT40 cells lacking both 
RECQ5 and BLM exhibited much higher levels of sister chromatid exchanges (SCEs) 
than a BLM-/- mutant (Wang et al., 2003). RECQ5 deficiency in Caenorhabditis elegans 
reduced lifespan and increased cellular sensitivity to ionizing radiation (Jeong et al., 
2003).  
 
 
Figure 30. Image showing the elevated frequency of SCEs in RECQ5 deficient cells. Representative 
metaphase spreads from wild-type (a) and RECQ5 deficient (b) mouse ES cells are shown here. Adapted 
from Hu et al., 2005. 
 
Complementation studies in yeast suggested that Drosophila RECQ5 
(DmRECQ5) was able to fully complement the sgs1 (yeast RecQ helicase) phenotypes 
of the synthetic growth defects with Srs2, the hypersensitivity to 
hydroxyurea/methylmethanesulfonate (MMS) and the elevated rate of SCEs, but very 
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poorly complemented the suppression of slow growth in topoisomerase III (Nakayama 
et al., 2004). They further showed that the C-terminus of DmRECQ5 was dispensable 
for complementing the sgs1 srs2 phenotype, but was required for complementation of 
sgs1 top3. Transgenic flies that overexpressed RECQ5 in their developing eye 
primordia showed mild roughening of the ommatidial lattice (Nakayama et al., 2006). 
Further, overexpression of RECQ5 perturbed the progression of the cell-cycle in 
response to DNA damage in the eye imaginal discs. Hu et al. showed that mouse 
embryonic stem cells lacking BLM or RECQ5 genes displayed a significant increase in 
the frequency of SCEs (Hu et al., 2005) (Figure 30). Further, deletion of both genes lead 
to an even higher frequency of SCE. Thus, these data suggested that BLM and RECQ5 
have non-redundant roles in suppressing crossovers during homologous recombination. 
Later, the same group showed that the deletion of RECQ5 in mice resulted in increased 
susceptibility to cancer, accumulation of spontaneous double-strand breaks and 
elevated frequencies of homologous recombination (HR) (Hu et al., 2007). 
3.4.8.3. Domain structure 
RECQ5 exists in at least three different isoforms, named RECQ5α, RECQ5β and 
RECQ5γ, resulting from alternative RNA splicing (Sekelsky et al., 1999; Shimamoto et 
al., 2000) (Figure 31). These proteins have the predicted molecular masses of 46 kDa, 
108.9 kDa and 49 kDa, respectively (Shimamoto et al., 2000). The first 410 amino acids 
of these isoforms are identical and constitute the helicase domain of the enzyme. 
RECQ5α is the shortest variant including only the helicase domain (410 amino acids). 
RECQ5β contains the helicase domain and a putative RQC domain, which is followed 
by a long C-terminal region that shows no homology with the other RecQ helicases. No 
putative HRDC domain was found present in RECQ5β. RECQ5γ includes the helicase 
domain followed by a C-terminal extension of 25 amino acids that is not present in 
RECQ5β. Interestingly, only the largest splice variant RECQ5β localizes to the nucleus, 
whereas the short isoforms are only present in the cytoplasm (Shimamoto et al., 2000). 
3.4.8.4. Biochemical properties 
Initial biochemical characterization of RECQ5 was done in Matson’s group using the 
Drosophila melanogaster (Dm) small isoform of RECQ5 (Ozsoy et al., 2001). The 
purified DmRECQ5 protein displayed ATP-/dATP-dependent 3’-5’ helicase activity on a 
M13 based partial duplex substrate. Later, the same group showed that the small 
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isoform of DmRECQ5 is a structure-specific helicase that is capable of unwinding forked 
DNA, 3’-flap/5’-flap duplexes, three-way and four way junctions (Ozsoy et al., 2003). 
Also, the protein showed a preference for unwinding the “lagging-strand arm” in a 
structure resembling a stalled replication forks (Ozsoy et al., 2003). Gel filtration 
experiments conducted by Kawasaki et al., indicated that the largest isoforms of RECQ5 
(DmRECQ5β) adopts an oligomeric structure (Kawasaki et al., 2002). Further, they 
showed that DmRECQ5β protein hrdrolyzed GTP, much more efficiently than ATP, in 
the presence of single-stranded (ss) DNA. Also, it was noticed that GTP stimulated the 
ATP-driven DNA unwinding activity of DmRECQ5.  
 
Figure 31. Schematic representation of human RECQ5α, RECQ5β and their homologues from 
Drosophila melanogaster (dmRECQ5c, dmRECQ5b and dmRECQ5a). Adapted from Ren et al., 
2008. 
 
The first biochemical characterization of human RECQ5 protein was conducted in 
our laboratory and published in 2004 (Garcia et al., 2004). It was found that human 
RECQ5β protein exist as monomer even in the presence DNA and nucleotide cofactors. 
Functional studies revealed that RECQ5β possesses two enzymatic activities: i) ATP-
dependent 3’-5’ helicase activity and ii) DNA strand-annealing activity. The human 
replication protein A (hRPA) was found to stimulate the helicase function and inhibit the 
strand-annealing activity of RECQ5β. It was also found that the strand-annealing 
function of RECQ5β resides in the unique C-terminal region of the protein. Further, it 
was found that the ATP-bound form of RECQ5β cannot promote strand annealing. Also, 
it was shown that human RECQ5β promoted the branch migration of synthetic Holliday 
junctions (Garcia et al., 2004). More recently, human RECQ5β protein was shown to be 
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capable of removing RAD51 from single-stranded DNA in a reaction that required ATP 
hydrolysis and RPA (Hu et al., 2007). For more biochemical properties of human 
RECQ5 helicase, see the chapter 4 & 5 of this thesis. 
3.4.8.5. Interaction partners and cellular roles 
The first reported interaction partners of RECQ5β were TOPO IIIα and TOPO 
IIIβ (Shimamoto et al., 2000). In this study, RECQ5β was found to co-immunoprecipitate 
with TOPO IIIα and TOPO IIIβ from HeLa cell extracts. The presence of this complex in 
the cell was further confirmed by immunocytochemical staining. However, the functional 
significance of this complex is still unknown. Based on cellular and biochemical studies, 
it was earlier proposed that RECQ5β may serve as a backup for BLM (Garcia et al., 
2004). However, later it was found that RECQ5β-TOPO IIIα complex was unable to 
effect the dissolution of DHJs (Wu et al., 2005).  
RECQ5 was found to directly interact with RAD51 protein, which function in the 
initiation of HR pathway (Hu et al., 2007). It was shown that RECQ5 deficient cells 
exhibited an increased frequency of RAD51 and γ-H2AX foci. Further, elevated 
frequency of HR-mediated repair was noticed in RECQ5 deficient cells. Taken together, 
these data indicated that RECQ5 deficiency is associated with increased DSB repair by 
HR. Also, it was shown that RECQ5 regulates HR and prevent aberrant recombination 
in the cells by suppressing RAD51-mediated D-loop formation (Hu et al., 2007) (Figure 
32). 
More recently, RECQ5β was shown to directly interact with RNA polymerase II 
(RNAPII) (Izumikawa et al., 2008). At least four RNAPII subunits were found associated 
with RECQ5β. It was found that RECQ5β is associated with hypo- and hyper-
phosphorylated forms of the largest subunit of RNAPII (Rpb1). Further, RECQ5β was 
found associated with the coding regions of the LDL receptor and β−actin genes, and 
knockdown of the RECQ5β transcript increased the transcription of those genes. 
Collectively, these data suggested that RECQ5β plays suppressive roles in events 
associated with RNAPII dependent transcription. More interaction partners of RECQ5 
are described in Chapter 4 & 5. 
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Figure 32. Proposed model for the mechanism of action of RECQ5 (here RECQL5) on Rad51 presynaptic 
filaments. RECQL5 utilizes the free energy from ATP hydrolysis to catalyze the dismantling of the Rad51 
presynaptic filament. The ssDNA generated as a result of Rad51 removal is immediately occupied by 
RPA to prevent the reloading of Rad51. Adapted from Hu et al., 2007. 
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4. Results  
 
The aim of this thesis is:  
(i) To characterize the biochemical properties and the cellular functions of the            
human RECQ5 protein, and 
(ii) To elucidate the function of the cellular complexes comprised of the Werner 
syndrome helicase and the mismatch repair (MMR) initiation proteins. 
 Significant findings of this thesis are described in the following sections. 
Publications that have arisen from this work are included in the Appendix. 
4.1. Human RECQ5β  helicase promotes strand exchange on synthetic 
DNA structures resembling a stalled replication fork 
 
RecQ helicases are an increasingly studied class of DNA unwinding enzymes. Recent 
studies have shown that, in addition to the helicase function, the human RecQ helicases 
RECQ1, BLM, WRN, RECQ4 and RECQ5 possess a single-strand-annealing (SSA) 
activity. Studies on the RECQ5 helicase revealed that its SSA activity resides in the 
unique C-terminal portion of the protein. These biochemical characteristics suggested 
that RECQ5 could be involved in DNA transactions that require coordinated action of 
helicase and strand-annealing activities such as replication fork regression. Fork 
regression is believed to facilitate DNA damage bypass during replication, allowing the 
replicative polymerase to use undamaged sister chromatid as a template for synthesis 
of the sequence complementary to the blocking lesion. Fork regression includes 
unwinding of the newly replicated arms of the fork, annealing of the nascent DNA 
strands and re-pairing of the parental strands to form a Holliday-Junction structure.           
Our results using the oligonucleotide based fork structures demonstrated that 
RECQ5β was capable of promoting strand exchange between arms of synthetic forked 
DNA structures that resembled a stalled replication fork in a reaction stimulated by 
human replication protein A (hRPA). This activity was not detected when ATP was 
substituted with its poorly hydrolysable analogue ATPγS, indicating that it is dependent 
on the helicase activity of RECQ5β. Although, similar strand exchange reactions were 
also seen with BLM and WRN, in the presence of hRPA, the action of these RecQ-type 
helicases was strongly biased towards unwinding of the parental duplex, an effect not 
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seen with RECQ5β. Collectively, these findings indicated that RECQ5β is capable of 
promoting fork regression in vitro.  
To further understand the mechanism of RECQ5β-mediated strand exchange, we 
have examined the action of RECQ5β on synthetic forked structures with non-
complementary arms to monitor DNA unwinding events associated with this reaction. 
The obtained results revealed that RECQ5β preferentially unwinds the lagging strand 
arm on such structures. This preference was dramatically enhanced upon addition of 
hRPA to the reaction. We also analysed the action of the BLM and WRN helicases 
using the same substrates. In contrast to RECQ5β, BLM and WRN displayed a strong 
preference for unwinding of the parental arm on all these structures. These results 
highlight mechanistic differences between RECQ5β and other human RecQ helicases in 
processing of forked DNA structures. Further work to identify the region of RECQ5β that 
is required for its ability to unwind the lagging strand arm of the fork revealed that the 
portion of RECQ5β spanning the amino acids 561-651 is critical for its strand-exchange 
activity, perhaps being involved in loading of the helicase on the three-way junction. 
 To explore whether RECQ5β acts at DNA replication forks in vivo, we 
investigated the sub-cellular localization of RECQ5β protein by indirect 
immunofluorescence imaging. These studies revealed that RECQ5β localizes 
exclusively to the nucleus. Using synchronized human cells, we found that RECQ5β is 
associated with the DNA replication machinery, particularly in early and late S phase, as 
revealed by the nearly complete co-localisation of RECQ5β foci with the foci formed by 
the replication processivity factor PCNA during those stages of cell cycle. We further 
found that the RECQ5β foci in late S co-localised with promyelocytic leukemia protein 
(PML), indicating that RECQ5β associates with PML nuclear bodies, a dynamic nuclear 
protein structure serving as DNA-damage sensors. We have also observed that 
RECQ5β forms discrete foci in response to DNA damage caused upon exposing cells to 
UVC irradiation and cisplatin treatment, and that these foci co-localize with the PCNA 
foci formed upon this damage. These data indicate that RECQ5β is present in 
replication-repair factories formed at the sites of stalled replication forks.  
In addition, we showed that RECQ5β directly interacts with PCNA in vivo and in vitro. 
We also found that the region spanning the last 200 amino acids of RECQ5β is 
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essential for its interaction with PCNA, suggesting that this interaction is mediated 
through the putative PCNA-binding motif (between amino acids 964-971) located in this 
region. These results further suggest that the observed recruitment of RECQ5β to 
replication foci may occur via a direct interaction with PCNA. 
 The data presented in this work showed that RECQ5β utilizes its helicase and 
SSA activities to promote strand exchange between arms of forked DNA structures 
resembling a stalled replication fork. Collectively, our findings suggest that RECQ5β 
mediates regression of stalled replication forks in vivo to facilitate damage bypass by 
template switching. This conclusion is consistent with the elevated level of mitotic 
crossovers observed in mouse cells upon inactivation of the RECQ5β homologue, as 
these can result from recombinational repair of broken replication forks (Figure 33).  
 
Figure 33. A model for the role of RECQ5β in suppression of mitotic recombination. A DNA lesion on the 
leading strand template causes replication fork stalling. RECQ5β promotes regression of stalled 
replication forks, which allow template switching to the undamaged chromatid. This prevents fork 
breakage and subsequent recombinational repair of DSBs that can result in sister chromatid exchanges 
(SCEs).  
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4.2. The zinc-binding motif of human RECQ5β suppresses the 
intrinsic strand annealing activity of its DExH helicase domain and is 
essential for the helicase activity of the enzyme 
 
Human RECQ5 protein exists in three different isoforms, namely RECQ5α (1 - 410 aa), 
RECQ5β (1 - 991 aa) and RECQ5γ (1 - 435 aa), resulting from alternative splicing of the 
RECQ5 transcript. The N-terminal 410 amino acids of these proteins are identical and 
include the set of seven conserved helicase motifs (helicase domain). 
RECQ5β additionally contains a putative zinc (Zn2+)-binding domain followed by a long 
non-conserved C-terminal region, whereas RECQ5γ possesses 25 amino acid C-
terminal extension that is not present in RECQ5β. The biochemical characteristics of the 
two short isoforms of RECQ5 are not known yet.  
We found that RECQ5α, which contain the conserved helicase motifs, did not 
exhibit ATPase and helicase activity although it was proficient in ATP binding. Our 
experiments further showed that the inability of RECQ5β to unwind DNA was caused by 
its failure to hydrolyze ATP. Surprisingly, like RECQ5β, the RECQ5α isoform was also 
able to promote annealing of complementary single-stranded oligonucleotides. In 
contrast to RECQ5β, ATP dramatically inhibited the annealing activity of RECQ5α. As 
shown for RECQ5β, we found that the strand annealing activity of RECQ5α was 
inhibited by human replication protein A (hRPA).  
Next, we investigated the minimal region of RECQ5 protein that is essential for its 
helicase function. Our results revealed that the region encompassing 410 – 475 amino 
acids of RECQ5β, which includes the putative Zn2+-binding motif, is crucial for the 
ATPase and helicase activities of the enzyme. Further, replacement of the cysteine 
residue at the position 431 with a serine (C431S) significantly reduced not only the Zn2+ 
binding capacity of RECQ5β, but also its ATPase and helicase activities. Additional 
band-shift experiments demonstrated that the Zn2+-binding motif confers the DNA 
binding ability to the RECQ5β helicase and it preferentially binds double-stranded (ds) 
DNA.  
Taken together, these data suggest that the Zn2+-binding motif regulates the 
enzymatic activity of RECQ5β,  i.e. it suppresses the strand-annealing function of the 
helicase domain and promotes strand separation.  
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4.3. The MRE11/RAD50/NBS1 complex links RECQ5 helicase to sites 
of DNA damage 
  
The molecular mechanisms that exist in mammalian cells to regulate homologous 
recombination events during mitosis are poorly understood. RECQ5 helicase is 
proposed to prevent inappropriate homologous-recombination events, but its exact role 
in DNA metabolism remains elusive. To shed more light on the cellular role of RECQ5, 
we initiated studies to determine the proteins interacting with RECQ5. Two different 
approaches were used: (i) Genetic approach that involves screening a human cDNA 
library by the yeast two-hybrid system using RECQ5 as bait, and (ii) Proteomic 
approach that involves analysis of RECQ5 immunoprecipitates from human cells by 
mass spectrometry. The most prominent interaction partner of RECQ5 identified by the 
mass spectrometry approach was the MRE11/RAD50/NBS1 (MRN) complex, an 
important factor in the cellular response to DNA double-strand breaks (DSBs). The 
cellular level of the RECQ5/MRN complex was not altered upon induction of different 
types of DNA damage or during different stages of the cell cycle, suggesting a 
constitutive association. Further, the direct interaction between RECQ5 and MRN was 
confirmed by performing affinity pull-down assays using purified recombinant proteins. 
The obtained results suggested that RECQ5 binds directly to the MRE11 and NBS1 
subunit of the MRN complex. The experiments with the NBS1 deficient cells revealed 
that the absence of NBS1 protein did not affect the complex formation between RECQ5 
and MRE11. Similarly, the complex formation between RECQ5 and NBS1 proteins was 
seen in MRE11-deficient cells, although the cellular level of NBS1 was dramatically 
reduced in MRE11-deficient cells.  
We next investigated the effect of MRN on the biochemical activities of RECQ5 
protein. Our results showed that the MRN complex did not significantly alter the helicase 
and strand-exchange activities of RECQ5. We then investigated the effect of RECQ5 on 
the nuclease activity of the MRN complex. Our results revealed that the 3’-5’ 
exonuclease activity of the MRN and MR complexes was inhibited by RECQ5, but not 
by the E. coli RecQ. Collectively, these data suggest that RECQ5 negatively regulate 
the MRN complex by attenuating its exonuclease function through direct interaction with 
the MRE11 protein.  
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To explore the function of the RECQ5/MRN complex in the maintenance of genomic 
stability, we used indirect immunofluorescence microscopy to examine whether these 
proteins co-localize at sites of DNA damage. We found that, in cells that have been 
exposed to DNA damaging agents, RECQ5 extensively co-localized with RAD50 in 
nuclear foci. Further, shRNA mediated MRE11 knockdown studies in U2OS cells 
revealed that MRE11 protein is essential for the recruitment of RECQ5 to sites of DNA 
damage. This result was further confirmed using MRE11-deficient ATLD1 cells.  
Collectively, these data suggest that RECQ5 helicase is recruited to sites of DNA 
damage through interaction with the MRN complex and inhibits MRE11-associated 
exonuclease activity.  
4.4. Physical and functional interactions between Werner syndrome 
helicase and mismatch-repair initiation factors 
 
The DNA mismatch-repair (MMR) system maintains genomic integrity by correcting 
DNA replication errors. It is also known that proteins involved in the initiation of post-
replicative MMR, such as MSH2, MSH6, MLH1 and PMS2, act during double strand 
break (DSB) repair to suppress recombination between homeologous (divergent) DNA 
sequences. Moreover, there is evidence in yeast suggesting the involvement of Sgs1 
helicase in the suppression of recombination between divergent DNA sequences. These 
findings led to the proposal that MMR proteins act in conjunction with Sgs1 to unwind 
DNA recombination intermediates containing mismatches. We initiated a project to 
check whether the same holds true in mammalian cells. In other words, we wanted to 
check whether Werner syndrome protein (WRN), the human orthologue of Sgs1 
helicase, and the MMR system cooperate in rejection of homeologous recombination 
(heteroduplex rejection).  
To this end, we initially checked whether WRN and MMR proteins bind directly to 
each other. Using ELISA-based protein-binding assay, we found that WRN interacted 
directly with MutSα (a heterodimer of MSH2/MSH6), MutSβ (a heterodimer of 
MSH2/MSH3) and MutLα (a heterodimer of MLH1/PMS2) proteins. Our co-
immunoprecipitation studies revealed that WRN formed a stable complex with MutLα, 
but not with MutSα in vivo. GST pull-down experiments using different fragments of 
WRN revealed the regions of WRN required for its interaction with MMR proteins. While 
all the three MMR proteins interacted with the helicase core region of WRN (500 - 946 
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amino acids), both MutSβ and MutLα also made additional contacts on WRN. 
MutSβ was found to interact with the winged-helix (WH) motif of WRN (947 – 1149 
amino acids), and MutLα was found to interact with the N-terminal region of WRN that 
includes the exonuclease domain (51 – 449 amino acids). To identify the subunits of 
MutSα, MutSβ and MutLα that mediate the interaction with WRN, we carried out a yeast 
two-hybrid (YTH) assay using the full-length WRN as prey. We found WRN to interact 
with MLH1 and MSH2, but not with MSH3 and MSH6, indicating that the MutSα − WRN 
and MutSβ- WRN interactions are mediated by MSH2, and the MutLα − WRN interaction 
is mediated by MLH1.  
 
                                        
Figure 34. A model showing heteroduplex rejection mediated by the MMR initiation factors and WRN 
helicase on SSA intermediates. First, a DNA mismatch present in the SSA intermediate is recognized by 
MutSα. Later, MutSα recruits the WRN helicase to unwind the annealed region and thereby prevent 
homeologous recombination. 
 
Functional studies indicated that both MutSα and MutSβ, but not MutLα, strongly 
stimulated the helicase activity of WRN specifically on forked DNA structures with a 3’-
single-stranded arm resembling strand-pairing intermediates of the single-strand-
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annealing (SSA) pathway of homologous recombination (HR). The stimulatory effect of 
MutSα on WRN-mediated unwinding was enhanced by the presence of a G/T mismatch 
in the DNA duplex ahead of the fork. Since MutLα is known to bind to MutSα-
heteroduplex complexes, we investigated whether it can affect the WRN-mediated 
unwinding of G/T and G/C substrates induced by MutSα. We found that MutLα did not 
significantly alter the MutSα-dependent helicase activity of WRN on these DNA 
structures. 
Collectively, our results support the model in which MMR proteins work in 
conjunction with a RecQ DNA helicase to disrupt HR intermediate containing 
mismatches (Figure 34). 
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5. Conclusion and future perspectives 
Defects in many DNA repair genes have been linked to tumorigenesis and tumor 
progression (Bartkova et al., 2005; Gorgoulis et al., 2005; Bartkova et al., 2006; Bartek 
et al., 2007), and hence these genes are classified as tumor suppressor genes. More 
than 150 human DNA repair genes have been identified thus far (Wood et al., 2005). 
Proteins belonging to the RecQ family of DNA helicases are conserved in evolution and 
play critical roles in the genome maintenance (Bachrati & Hickson, 2003). Studies over 
the last decade have identified human RecQ helicases (RECQ1, WRN, BLM, RECQ4 
and RECQ5) as an important tumour suppressor proteins and the loss of which cause 
genomic instability (Hanada & Hickson, 2007; Brosh & Bohr, 2007). Also, the published 
data suggested that each of these helicases play unique roles in the maintenance of 
genome stability. However the exact DNA transactions mediated by these proteins and 
the DNA repair pathways in which they act are currently unclear. 
In the first work (Kanagaraj et al., 2006), we showed that the human RECQ5 
helicase possesses the ability to promote strand exchange on synthetic forked DNA 
structures that mimic a stalled replication fork. Moreover, RECQ5 protein was found to 
be present at the DNA replication factories in S phase cells and persisted at the sites of 
stalled replication forks. Also, RECQ5 was found to associate with PCNA in vitro and in 
vivo. Based on these findings, we proposed that the RECQ5 helicase could mediate 
regression of stalled replication forks in vivo to facilitate DNA damage bypass by 
template-switching mechanism (Higgins et al., 1976; Cox, 2001; Sogo et al., 2002). This 
could explain the finding that inactivation of the mouse RECQ5 homologue is associated 
with a significant increase in the frequency of sister chromatid exchanges (SCEs) (Hu et 
al., 2005).  
Recent studies from Dr. David Orren’s and Dr. Leonard Wu’s laboratories have 
shown that the other human RecQ helicases namely BLM and WRN also could mediate 
strand exchange and fork regression (Machwe et al., 2005; Ralf et al., 2006; Machwe et 
al., 2006; Machwe et al., 2007), suggesting a role for these proteins in template 
switching. It should be noted that strand exchange activity of BLM and WRN was also 
shown in our work (Kanagaraj et al., 2006), and in addition we have shown that the 
human replication protein A (hRPA) blocked strand exchange mediated by BLM and 
WRN, but not by RECQ5. Hence, to assess which human RecQ helicase is more likely 
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to promote fork regression in vivo, the effect of hRPA on fork regression by BLM, WRN 
and RECQ5 should be examined.  
On the other hand, a very recent finding from Dr. Lajos Haracska’s laboratory on 
the yeast Rad5 protein has made the role of human RecQ helicases in template 
switching rather questionable. In the budding yeast, fork regression associated with 
template switching is thought to be the underlying mechanism of the RAD5-subpathway 
of RAD6-dependent postreplicative repair, which is highly conserved from yeast to 
humans (Torres-Ramos et al., 2002). As this DNA damage tolerance process, which 
involves non-destructive polyubiquitination of PCNA, is largely independent of the HR 
machinery, other means such as helicase-promoted DNA unwinding, would be required 
for fork regression (Torres-Ramos et al., 2002; Hoege et al., 2002). Biochemical 
evidence published by Blastyák et al., have shown that the Rad5 protein concertedly 
unwinds and anneals the nascent and the parental strands in the stalled forks without 
exposing extended single-stranded regions, and hence it seems to be a good candidate 
for the enzyme responsible for promoting fork regression in vivo (Blastyák et al., 2007).  
Two recent publications have questioned the template-switching model (Lopes et 
al., 2006 and Heller & Marians, 2006). These studies established that DNA lesions in 
the leading strand did not block replication, but temporarily stalled the fork, and DNA 
synthesis was resumed following a repriming event downstream of the DNA lesion, thus 
leaving a gap opposite the lesion. Also, these results argued for a discontinuous mode 
of leading-strand synthesis and provided additional support for similar findings 
previously reported (reviewed in Ogawa & Okazaki, 1980). Further, these data 
suggested that lesion need not be repaired, and neither fork regression nor fork 
breakage is required in order to resume DNA synthesis.  
Taken together, it is more likely that the increased level of mitotic recombination 
observed in RECQ5 deficient cells (Hu et al., 2005) is due to a defect in another DNA 
repair mechanisms (see below). In support of this, Luo’s and Sung’s laboratories have 
recently obtained evidence suggesting that RECQ5 suppresses unscheduled 
recombination during DNA replication by disruption of inappropriately formed RAD51 
presynaptic filaments (Hu et al., 2007) in the same manner as the Srs2 (Krejci et al., 
2003) and UvrD helicases (Veaute et al., 2005). Moreover, RECQ5 was found to be 
present at the ongoing DNA replication factories and at the sites of stalled DNA 
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replication forks (Kanagaraj et al., 2006). Therefore, it is more likely that RECQ5 
functions primarily during S-phase and hence one may address the following questions 
in the future: 1) Do RECQ5 deficient cells exhibit defect in DNA replication? 2) Do cells 
require RECQ5 for efficient replication-fork restart after replication blockade?  
In the second work (Ren et al., 2008), we have identified an essential function for 
the zinc (Zn2+)-binding domain (379-454 aa) of human RECQ5 protein. Our work had 
showed that the Zn2+-binding motif of RECQ5 suppresses strand-annealing activity 
residing in the N-terminal helicase domain (1-410 aa) of the protein. Further, our results 
illustrated that the Zn2+-binding motif of RECQ5 is important for DNA binding and 
therefore is essential for the strand-separation activity of the enzyme. The involvement 
of the Zn2+-binding motif in the DNA binding was also shown previously for the E.coli 
RecQ and human BLM helicases (Liu et al., 2004; Guo et al., 2005). Interestingly, 
human RECQ4, which does not contain the conserved Zn2+-binding domain failed to 
unwind DNA (Macris et al., 2005). Taken together, all these data establish a clear link 
between the presence of the Zn2+-binding motif and the helicase activity of RecQ 
helicases. 
Our future goal is to understand the complete domain organization of the human 
RECQ5 helicase. In addition to the conserved helicase domain, RecQ helicases contain 
additional domains flanking the helicase motif (Bachrati and Hickson, 2003). In some 
RecQ helicases, additional enzymatic activities have been found to reside in those 
flanking regions. The WRN protein was found to exhibit a 3’-5’ exonuclease activity 
residing in its unique N-terminal region (Huang et al., 1998; Kamath-Loeb et al., 1998). 
The unique C-terminal region of RECQ5 helicase was found to retain a strand-annealing 
activity (Garcia et al., 2004). The Helicase and RNaseD C-terminal (HRDC) domain of 
the BLM helicase was shown to be essential for the dissolution of double-Holliday 
junctions by BLM/TOPO IIIα complex (Wu et al., 2005). The N-terminal domain of 
RECQ4 helicase that bears sequence homology to the yeast replication factors 
Sld2/DRC1 was shown to be important for the initiation of DNA replication (Sangrithi et 
al., 2005).   
Our bioinformatics analysis of the human RECQ5 protein revealed the presence of two 
conserved motifs in the C-terminal part of the RECQ5 polypeptide. The first is 
Translocation RecG (TRG) motif that has been earlier discovered in the E.coli Mfd 
 89 
protein (Mahdi et al., 2003; Chambers et al., 2003), a transcription-repair coupling factor 
capable of disrupting stalled transcription complexes (Park et al., 2002; Chambers et al., 
2003; Saxowsky & Doetsch, 2006). The second is Set2-Rpb1 Interacting (SRI) domain 
that has been shown to bind specifically and with a high affinity to the doubly 
phosphorylated CTD repeats of RNA polymerase II (Kizer et al., 2005). The 
identification of these two motifs has led to the proposal that RECQ5 helicase might be 
involved in the disruption of stalled transcription complexes. This question will be 
addressed in our future studies.  
To gain insights into the biological functions of RECQ5, we initiated studies to 
identify the interaction partners of RECQ5. We have discovered a strong interaction 
between the human RECQ5 protein and the MRE11/RAD50/NBS1 (MRN) complex in 
vitro and in vivo (Zheng et al., manuscript to be submitted). Upon genotoxic stress, 
RECQ5 and MRN proteins were found to simultaneously accumulate at sites of stalled 
DNA replication forks and DNA double strand breaks (DSBs). Moreover, we showed 
that MRE11 is required for the foci formation of RECQ5 following DNA damage. The 
observed defect in RECQ5 foci formation was unlikely caused by reduced level of the 
RECQ5 protein, since comparable amounts of RECQ5 were found in MRE11 proficient 
and deficient cells. In addition, our biochemical studies revealed that RECQ5 negatively 
regulates the MRN complex by attenuating its 3’-5’ exonuclease activity. Collectively, 
these data suggest a functional interplay between the RECQ5 helicase and the MRN 
complex. Certainly, more work is required to elucidate the exact DNA transactions 
mediated by this helicase – nuclease complex. The questions that should be addressed 
in future are highlighted below.  
The MRN complex was shown to play critical roles in DNA DSB repair, G2/M 
checkpoint activation, telomere length maintenance, meiotic recombination and the 
maintenance of genome stability during DNA replication (D’Amours & Jackson, 2002; 
van den Bosch et al., 2003). Accumulating evidence suggest that the MRN complex 
acts as a DSB sensor through its DNA-end processing activities and activates the ATM-
dependent signaling pathways that co-ordinate cell cycle arrest with DNA repair 
(Williams et al., 2007; Lavin, 2007). However, the factors involved in the control of this 
resection process remain uncertain. Evidence from Tanya Paull’s laboratory suggested 
that the activities of MRN complex could be controlled by the adenylate kinase activity of 
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RAD50 (Bhaskara et al., 2007). In addition, two works published recently have shown 
that CtIP promotes DNA DSB resection in a manner dependent on the MRN complex 
(Limbo et al., 2007; Sartori et al., 2007). Our finding that RECQ5 inhibits the 3’-5’ 
exonuclease activity of the MRN complex adds one more controlling mechanism that 
prevents malfunctioning of the MRN complex and thereby allows the proper repair of 
DNA DSBs via homologous recombination (HR). Another attractive possibility could be a 
cooperative role of RECQ5 helicase and MRN nuclease in the regulation of HR. It is well 
known that the MRN complex is involved in the initial resection step of DNA DSB repair 
(D’Amours & Jackson, 2002). Recent studies suggested that RECQ5 negatively 
regulates the early step of HR by dismantling the hRAD51 filament (Hu et al., 2007). 
Hence, it will be of primary interest now to test the effect of MRN complex on this activity 
of RECQ5. Since our results (Zheng et al., manuscript to be submitted) clearly 
demonstrated that the MRN complex function as a recruitment factor for RECQ5 upon 
DNA damage, one can speculate that RECQ5-MRN complex acts as an anti-
recombinase by preventing malfunctioning of hRAD51.  
  Apart from the 3’-5’ exonuclease activity, the MRN complex was shown to possess 
an endonuclease activity specific for hairpin structures and the 3’-single-stranded DNA 
tail (Trujillo et al., 1998; Paull & Gellert, 1999; Trujillo & Sung, 2001). Hence, it will be 
interesting to check the effect of RECQ5 protein on this activity of MRN using similar 
substrates. Based on speculation that the MRN complex might mediate the 
endonucleolytic cleavage of the 5’-strand at secondary structures formed upon DNA 
unwinding, one can check whether the lagging strand liberated by the action of RECQ5 
on substrate mimicking a stalled fork (with a gap on leading strand) is processed by the 
MRN endonuclease. In this case, one may assume that the unwound lagging strand 
could form a hairpin structure and thereby it serves as substrate for MRN cleavage. 
Similar model had been proposed earlier for E.coli RecQ and RecJ exonuclease 
(Courcelle & Hanawalt 1999; Morimatsu & Kowalczykowski 2003; Hishida et al., 2004). 
It was demonstrated that RecQ helicase in conjunction with RecJ, both belonging to the 
RecF pathway of recombinational repair, promoted degradation of nascent DNA on the 
lagging strand at blocked replication forks and subsequent events promoted recovery 
from DNA damage via homologous recombination (HR). Also, we believe that such an 
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action in mammalian cells may help stabilize the replication fork allowing resumption of 
DNA synthesis following the removal of DNA damage.       
Previous studies conducted with BLM and WRN demonstrated that these 
proteins interacted physically and functionally with the MRN complex (Franchitto & 
Pichierri, 2002; Cheng et al., 2004; Franchitto & Pichierri, 2004). Similar to RECQ5, 
WRN was found recruited to the sites of DNA damage via the MRN complex (Franchitto 
and Pichierri, 2004). BLM was shown to be required for correct relocalization of the 
MRN complex after replication fork arrest (Franchitto and Pichierri, 2002). Further 
studies will be needed to fully understand the molecular mechanisms by which the 
RecQ helicases and MRN proteins work together to maintain genomic stability.  
Finally, we demonstrated that WRN interacts physically with proteins that are 
involved in the initiation of mismatch repair (MMR) and the rejection of recombination 
between divergent sequences (Saydam et al., 2007). Most importantly, our 
experiments revealed that MutSα and MutSβ can stimulate the helicase activity of WRN 
on forked DNA structures with a 3’-single-strand (ss) arm that resemble intermediates of 
single-strand annealing (SSA) pathway of homologous recombination (HR). In addition, 
we found that a single G/T mismatch located ahead of the fork junction increased the 
efficiency of the MutSα-dependent unwinding by WRN. Our data provide a biochemical 
evidence for a model that had been proposed earlier in yeast in which the MMR 
initiation factors prevent homeologous recombination by activating a DNA helicase for 
unwinding of recombination intermediates containing mismatches (Sugawara et al., 
2004; Goldfarb & Alani, 2005). 
Obviously, the detailed functional aspects of the observed interactions have to be 
addressed in the course of future studies. Both the MMR system and the WRN helicase 
are multifunctional enzymes that are known to play a vital role in several different 
pathways of DNA metabolism (Jiricny, 2006; Hanada & Hickson, 2007). We have 
recently found that like WRN, MMR proteins accumulate at the sites of laser-induced 
DNA DSBs (Lan et al., 2005; unpublished observation). In future, we will learn how the 
interaction between the MMR factors and WRN affect the outcome of mitotic 
recombination events. 
G-quadruplex structures, which can readily form in G-rich genomic loci such as 
immunoglobulin class switch regions or telomeric repeats, form a barrier for progression 
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of DNA replication forks. Recently, human MutSα has been shown to bind efficiently to 
G-quadruplex DNA, which is a preferred substrate for both BLM and WRN (Mohaghegh 
et al., 2001; Larson et al., 2005). Moreover, Msh2 deficiency in mice is associated with 
loss of telomeres and an elevated level of telomere end-to-end fusion, a phenotype 
similar to that manifested by WRN-deficient cells (Crabbe et al. 2004; Campbell et al. 
2006). Taken together, it is now tempting to speculate that the MMR proteins might 
mediate recruitment of the WRN helicase to G-quadruplex structures formed at 
telomeres and hence facilitate their removal.    
In our work (Saydam et al., 2007), we found that MutLα did not alter the WRN-
mediated unwinding of substrates mimicking the SSA intermediates, even in presence 
of MutSα or MutSβ. Our data are consistent with the yeast finding that the Mlh1 and 
Pms1 proteins have only minor roles in the rejection of homeologous recombination in 
vivo (Sugawara et al., 2004). Therefore, the direct interaction identified between WRN 
and MutLα might have another functional implication. Interestingly, we found that the 
MLH1 protein is located in the PML nuclear bodies (NBs), irrespective of the presence 
or absence of DNA damage (unpublished observation). These dynamic nuclear protein 
structures serve as DNA-damage sensors and are implicated in several DNA-repair 
pathways as well as in alternative lengthening of telomeres (ALT) via homologous 
recombination (Dellaire and Bazett-Jones, 2004). WRN has been shown to localize to a 
subset of PML NBs after DNA damage or in S phase of ALT cells (Blander et al., 2002; 
Opresko et al., 2004). Therefore, it is possible that the recruitment of WRN to these 
structures could be facilitated through a direct interaction with MLH1. Moreover, it 
remains to be seen whether inactivation of the MMR system in Werner syndrome cells 
will further increase genomic instability in these cells. Such studies will shed more light 
on the molecular mechanisms underlying the process of tumorigenesis. 
In conclusion, the findings described in this thesis significantly advance our 
understanding of the biological role of the human RecQ helicases and provide good 
basis for future work on these important guardians of genome integrity.  
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7.1.  Appendix I: Human RECQ5β helicase promotes strand exchange on 
synthetic DNA structures resembling a stalled replication fork 
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7.2.  Appendix II: The zinc-binding motif of human RECQ5β suppresses 
the intrinsic strand-annealing activity of its DExH helicase domain 
and is essential for the helicase activity of the enzyme
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7.3.  Appendix III: The MRE11/RAD50/NBS1 complex links RECQ5 
helicase to sites of DNA damage 
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ABSTRACT 
RECQ5 DNA helicase acts as a suppressor of homologous recombination, but its exact role in 
DNA metabolism remains elusive. Here, we show that RECQ5 interacts physically and 
functionally with the MRE11/RAD50/NBS1 (MRN) complex, a nuclease that is involved in the 
recognition and repair of DNA double-strand breaks (DSBs). The cellular concentration of the 
RECQ5/MRN complex was not enhanced by DNA damage or by synchronizing cells in a 
particular stage of the cell cycle, suggesting a constitutive association. Experiments with purified 
proteins suggested that the RECQ5/MRN complex was mediated by direct binding of RECQ5 to 
MRE11 and NBS1. Functional assays revealed that RECQ5 strongly inhibited the 3’-5’ 
exonuclease activity residing in the MRE11 protein. At the cellular level, the MRE11 protein was 
required for the recruitment of RECQ5 to sites of arrested replication forks and sites of laser-
induced DSBs. Collectively, these data suggest a functional relationship between RECQ5 and the 
MRN complex in the cellular response to DNA damage. 
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INTRODUCTION 
Proteins belonging to the RecQ DNA helicase family are highly conserved from bacteria to man. 
In humans, five RecQ homologues have been identified and named RECQ1, BLM, WRN, RECQ4 
and RECQ5. Inherited defects in the genes encoding for BLM, WRN and RECQ4 have been found 
to cause distinct recessive disorders associated with various forms of genomic instability, 
premature aging and predisposition to cancer (14). Numerous biochemical and cellular studies 
have shown that the multiple RecQ homologues in human cells have non-redundant roles in the 
maintenance of genomic stability (32). Several lines of evidence suggest that BLM suppresses 
crossovers during homologous recombination (HR) through its unique ability to act in conjunction 
with DNA topoisomerase IIIα to decatenate recombination intermediates containing double 
Holliday junctions (39, 40). WRN acts specifically at telomeres to promote lagging-strand 
replication of G-rich telomeric regions, preventing telomere erosion and subsequent recombination 
(7, 8). RECQ4 is proposed to be important for the initiation of DNA replication by promoting the 
loading of replication protein A (RPA) on unwound origins (29). 
 The role of the human RECQ5 protein in the maintenance of genomic stability is not well 
understood. RECQ5 exists in at least three different isoforms resulting from alternative RNA 
splicing (31, 33). However, only the largest splice variant of RECQ5, named RECQ5β, localizes 
to the nucleus and functions as DNA helicase in vitro (13, 33). Like other RecQ helicases, 
RECQ5β can promote branch migration of Holliday junctions and exhibits strand-annealing and 
strand-exchange activities (13, 17). It also possesses the ability to disrupt RAD51 presynaptic 
filament in a reaction dependent on its ATPase activity and the presence of RPA (16). In 
proliferating cells, RECQ5β associates with the replication machinery and accumulates at the site 
of stalled replication forks (17). Hereafter RECQ5β will be referred to as RECQ5. 
 Mice lacking the Recql5 gene are viable, but they are highly prone to various types of 
cancer (16). Recql5-deficient cells accumulate Rad51 and γ-H2AX foci and are prone to gross 
chromosomal rearrangements in response to replication stress (16). Moreover, Recql5-deficiency 
is associated with a significant increase in the frequencies of spontaneous sister-chromatid 
exchanges and DSB-induced HR (15, 16). These finding establish Recql5/RECQ5 as a tumor 
suppressor that plays a role in the control of HR, possibly through disruption of inappropriately 
formed Rad51 filaments (16). 
 The MRE11/NBS1/RAD50 (MRN) complex is an ATP-stimulated nuclease that exhibits a 
robust double-stranded (ds) DNA-dependent 3’-5’ exonuclease activity and it can also act 
endonucleotically on single-stranded DNA and harpins (27, 28, 37). The nuclease domain of this 
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complex is located in the MRE11 subunit, while the ATP hydrolysis is mediated by the RAD50 
subunit that contains a bipartite ATP binding domain split by a long repeat region that fold into an 
anti-parallel coiled-coil domain (1). The coiled-coil domain of RAD50 can dimerize via a hook 
structure located on the tip of this domain, which gives the MRN complex the capacity to tether 
DNA ends (1, 10). 
 The MRN complex is required for the maintenance of the integrity of DNA replication 
forks, DSB repair, G2/M checkpoint activation, telomere length maintenance and meiotic 
recombination (9). Accumulating evidence suggest that it acts as a DNA DSB sensor through its 
DNA-end processing activities and activates the ATM-dependent signaling pathways that co-
ordinate cell cycle arrest with DNA repair (18, 19). In higher eukaryotes, null mutations in all 
components of the MRN complex are lethal (22, 41, 42), while hypomorphic mutations in the 
human MRE11 and NBS1 genes can give rise to Ataxia telangiectasia-like disease (ATLD) and 
Nijmegen breakage syndrome (NBS), respectively, that are characterized by neurological 
abnormalities, radiosensitivity, genomic instability and cancer predisposition (3, 24, 34).  
 Here we show that the RECQ5 helicase and the MRN complex constitutively interact in 
vivo. The interaction is direct and is mediated through MRE11 and possibly through NBS1. 
RECQ5 and the MRN complex colocalize in the nucleus in response to replication arrest and 
chromosomal breakage. We further show that the recruitment of RECQ5 to site of DNA damage is 
dependent on the presence of the MRE11 protein. Moreover, our biochemical experiments reveal 
that RECQ5 strongly inhibits the 3’-5’ exonuclease activity associated with the MRE11 protein. 
Together, these data suggest that a functional relationship between RECQ5 and the MRN complex 
in the cellular response to DNA damage. 
 
MATERIALS AND METHODS 
Protein purification 
The RECQ5 protein was produced in bacteria as fusions with self-cleaving chitin-binding domain 
(CBD) and purified as described previously (13). Baculoviruses expressing (His)6-MRE11, (His)6-
NBS1 and RAD50, respectively, were a kind gift from Dr. Vilhelm Bohr. The MRN and MR 
complexes as well as the individual MRN subunits were produced in Sf9 cells infected with 
appropriate baculoviruses. Cells harvested at 72 hours after infection were suspended in buffer A 
[50 mM sodium phosphate (pH 7.0), 0.3 M NaCl, 0.5% Tween 20, 10% glycerol, 2 mM β-
mercaptoethanol] supplemented with 20 mM imidazole and 2 mM phenylmethylsulfonylfluoride 
(PMSF), and disrupted by sonication. Cell extract was clarified by centrifugation at 100,000 × g 
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for 1 hour and loaded on a 5-ml HiTrap Chelating (Ni2+) column (GE Healthcare) equilibrated with 
buffer A/20 mM imidazole. Bound proteins were eluted with a linear concentration gradient of 
imidazole (50 ml; 50 mM to 350 mM) in buffer A. Fractions containing MRN proteins were 
pooled, dialyzed against buffer B [20 mM Tris–HCl (pH 8.0), 100 mM NaCl, 10% glycerol and 1 
mM DTT] and loaded onto a 1-ml HiTrap Q Sepharose FF column (GE Healthcare). Bound 
proteins were eluted with a linear concentration gradient of NaCl (12 ml; 50 mM to 500 mM) in 
buffer B. Rad50 was purified only on a 1-ml HiTrap Q Sepharose FF column as it was expressed 
without a histidine tag. Purified proteins we stored at -80°C. Protein concentration was determined 
using Bradford assay. 
Antibodies 
Rabbit polyclonal antibody against the C-terminal portion of RECQ5 (amino acids 675–991) was 
affinity purified as described previously (17). Additionally, the following commercially available 
antibodies were used in this study: mouse monoclonal anti-MRE11 antibody, clone 12D7 (Novus 
Biologicals), mouse monoclonal anti-RAD50 antibody, clone 13B3 (GeneTex), rabbit polyclonal 
anti-NBS1 antibody, ab-398 (Abcam), mouse monoclonal anti-γ−H2AX antibody, clone JBW301 
(Upstate Biotechnology), rabbit polyclonal anti-TFIIH p89 antibody, sc-269 (Santacruz 
Biotechnology), mouse monoclonal anti-RAD51 antibody, ab1837 (Abcam) and rabbit polyclonal 
anti-ATM antibody (Abcam). 
Cell culture and generation of DNA damage 
U2OS, HeLa and 293T cells were maintained in Dulbecco modified Eagle’s medium (DMEM; 
OmniLab) supplemented with 10% fetal calf serum (FCS; Life Technologies) and 
streptomycin/penicillin (100 U/ml). Immortalized ATLD1 cells transduced with retrovirus 
expressing the wild-type MRE11 cDNA (ATLD1-MRE11) or retrovirus harboring the empty 
vector were obtained from Dr. Weitzman (4) and grown in DMEM supplemented with 20% FCS, 
streptomycin/penicillin (100 U/ml) and 1µg/ml puromycin (Sigma-Aldrich). NBS cells stably 
transfected with vector containing the wild-type NBS1 cDNA (NBS-NBS1) as well as the parental 
NBS cells (GM7166 VA7) were obtained from Dr. Y. Shiloh (35). Cultures of NBS-NBS1 cells 
were supplemented with hygromycin B (100 µg/ml). If required, cells were treated with 2 mM 
hydroxyurea (HU) for 16 hours, 1 µM camptothecin (CPT) for 16 hours or 20 µM cis-
diamminedichloroplatinum (CDDP) for 8 hours. Laser microirradiation to generate DNA DSBs in 
defined nuclear volumes was performed using a MMI CELCUT system containing a UVA laser of 
355 nm (Molecular Machines & Industries). Prior to irradiation, cells were grown for 24 hours in 
the presence of 10 µM bromodeoxyuridine (BrdU). Ionizing radiation was generated using a 
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Faxitron X-ray system. UV irradiation (at a dose of 40 J/m2) was performed in a UV-Stratalinker 
1800 equipped with a 254 nm UV lamp (Stratagene). Immediately after exposure to radiation, cells 
were placed back to incubator and incubated for various periods of time as indicated. For cell 
cycle analyses, ethanol-fixed cells were stained with propidium iodide (20 µg/ml; Molecular 
Probes) and subjected to flow cytometry in a Becton Dickinson cell sorter. 
RNA interference  
To knock down MRE11 expression in human cells by RNA interference (RNAi), we employed 
short-hairpin (sh) RNA technology. The following pairs of oligonucleotides were annealed and 
ligated into the pSUPER vector (Oligoengine) digested with HindIII and BglII: shRNA#1-top (5’-
gatccccacaggagaagagatcaactttcaagagaagttgatctcttctcctgttttttggaaa-3’)/shRNA#1-bottom   (5’-
agcttttccaaaaaacaggagaagagatcaacttctcttgaaagttgatctcttctcctgtggg-3’) and shRNA#2-top (5’-
gatccccgagcataactccataagtattcaagagatacttatggagttatgctctttttggaaa-3’)/shRNA#2-bottom 
(agcttttccaaaaagagcataactccataagtatctcttgaatacttatggagttatgctcggg). The regions homologous to the 
MRE11 sequence are underlined in each oligonucleotide. For control RNAi experiments, the 
oligonucleotides shRNA-C-top (5’-
gatccccagacgtgtacacaactagtttcaagagaactagttgtgtacacgtcttttttggaaa-3’) and shRNA-C-bottom (5’-
agcttttccaaaaaagacgtgtacacaactagttctcttgaaactagttgtgtacacgtctggg-3’) were annealed and processed 
as above. These oligonucleotides were designed by scrambling of the shRNA#1 sequence within 
the MRE11 homology region. The resulting plasmid constructs were further modified by 
introducing a puromycin resistance marker. To do so, the 1.4 kb BamHI/PvuI fragment of pPUR 
(Clontech) was ligated into the BamHI and SmaI sites of the pSUPER derivatives. The shRNA 
plasmids were introduced into U2OS cells by liposomal trasfection with Metafectene (Biontex) 
according to the manufacturer instructions. At 24 hours post transfection, cell cultures were 
supplemented with puromycin (2 µg/ml) to enhance the fraction of shRNA-expressing clones. 
Cells were usually harvested 3 days after addition of puromycin and further analyzed. 
Immunofluorescence staining and analyses 
Cells grown on cover slips were fixed in methanol for 30 min at -20°C, which was followed by 
incubation in acetone for 30 s. After blocking in PBS supplemented with 2% FCS (blocking 
solution), cover slips were incubated overnight at 4°C with appropriate primary antibodies [rabbit 
polyclonal anti-RECQ5 (1:1000), mouse monoclonal anti-RAD50 (1:200), mouse monoclonal 
anti-γ-H2AX (1:200); all antibodies were diluted in blocking solution]. After washing with PBS, 
the cells were incubated with FITC-conjugated sheep anti-rabbit (Sigma; dilution of 1:700) and 
Texas Red-conjugated donkey anti-mouse (Abcam; dilution of 1:200) secondary antibodies for 1 
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hour at room temperature. The cover slips were then mounted with Vectashield (Vector Labs) and 
sealed. Images were captured by an Olympus IX81 fluorescence microscope. At least 150 nuclei 
were analyzed in each experiment. 
Immunoprecipitation assay 
Cells grown in a 10 cm dish were subjected to trypsinization, harvested by centrifugation and 
suspended in 0.5 ml of lysis buffer [50 mM Tris–HCl (pH 8.0), 120 mM NaCl and 0.5% (v/v) NP-
40] supplemented with a protease inhibitor cocktail (Complete, Mini; Roche). After a 30-minute 
incubation on ice, the lysate was treated with 50 U of RNase-free DNase I (Roche) at 25°C for 30 
minutes, and clarified by centrifugation. In some cases, DNAse I was omitted or the lysates were 
supplemented with ethidium bromide (EtBr) to a final concentration of 50 µg/ml. The protein 
extract (1 mg of total protein) was incubated overnight at 4°C with purified rabbit anti-RECQ5 
IgGs (1 µg) or with IgGs purified from pre-immune serum (1 µg). Immune complexes were 
subsequently incubated with protein A/G–agarose beads (20 µl, GE Healthcare) for 1 hour at 4°C. 
Immunoprecipitates were analyzed by Western blotting. 
CBD pull-down assays 
CBD-tagged RECQ5 was produced in E. coli BL21-CodonPlus(DE3)-RIL cells (Stratagene) and 
bound to chitin beads (20 µl; NEB) in NET-150 buffer [10 mM Tris (pH 8.0), 1 mM EDTA, 150 
mM NaCl and 0.1% (v/v) Triton X-100]. The beads were incubated with recombinant MRN 
proteins (0.5–2 µg) in 400 µl of NET-150 buffer supplemented with ethidium bromide (50 µg/ml) 
for 2 hour at 4°C. Bound proteins were analyzed by Western blotting. 
Strand exchange assays 
Strand-exchange assays with RECQ5 were performed essentially as described previously (17). 
Briefly, reactions were carried at 37°C in buffer containing 20 mM Tris–acetate (pH 7.9), 50 mM 
KOAc, 10 mM Mg(OAc)2, 1 mM DTT and 50 mg/ml BSA. 1 nM DNA substrates (60-mer/30-mer 
partial duplex and complementary 60-mer oligonucleotide, of which the former 60-mer 
oligonucleotide was radiolabeled at 5’ end) were preincubated with 40 nM RECQ5 for 10 minutes 
to form a forked duplex. RECQ5-mediated strand exchange between the arms of the fork was 
initiated by addition of ATP (2 mM). Where required, the annealing mixture was preincubated 
with 40 nM MRN complex for 5 minutes prior to addition of ATP. Aliquots (5 µl) from different 
reaction time points were subjected to electrophoresis in 10% non-denaturing polyacrylamide gel 
(acrylamide/bis-acrylamide 19:1) run in 1xTBE buffer at 140 V. Gels were dried and subjected to 
phosphor-imaging analysis using a Typhoon 9400 scanner. 
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Nuclease assays 
The 3’-5’ exonuclease activity of the MR(N) complex was measured using a 5’-tailed oligoduplex 
prepared by annealing of a 30-mer oligonucleotide (5’-ggagtaaagtactaggtatgtcgacattga-3’) to the 
3’-half of a 60-mer oligonucletide (5’-
gaggtcactccagtgaattcgagctcgcagtcaatgtcgacatacctagtactttactcc-3’). The 30-mer oligonucleotide was 
radiolabeled at 5’-end prior to annealing. Reactions were conducted at 37°C in buffer containing 
30 mM MOPS (pH 7.0), 25 mM KCl, 1 mM DTT, 2 mM MnCl2, 2 mM ATP and 50 mg/ml BSA. 
Reaction mixtures contained 1 nM DNA substrate, 40 nM MR(N) and varying concentrations 
RECQ5 or E.coli RecQ, ranging from 0 to 80 nM. MR(N) and RECQ5 (RecQ) were pre-incubated 
for 5 minutes on ice before adding to the DNA substrate. Reactions were terminated after 30 
minutes by adding an equal volume of stop solution [80% (v/v) formamide, 10 mM EDTA, 0.1% 
(w/v) bromophenol blue and 0.1% (w/v) xylene cyanol] and heating at 95°C for 5 minutes. 
Reaction aliquots were subjected to electrophoresis in 15% (w/v) polyacrylamide gel containing 8 
M urea (acrylamide/bis-acrylamide 19:1) run in 1x TBE buffer at 300 V. Gels were dried and 
subjected to phosphor-imaging analysis using a Typhoon 9400 scanner. 
 
RESULTS 
Physical interaction between RECQ5 and the MRN complex 
To explore the cellular role of the human RECQ5 helicase, we employed a proteomic approach to 
identify proteins associated with RECQ5 in vivo. Specifically, we immunoprecipitated RECQ5 
from the total extract of human embryonic kidney cells (HEK 293T) using an affinity-purified 
rabbit polyclonal anti-RECQ5 antibody and analyzed the identity of co-precipitated proteins by 
mass spectrometry following their separation on a SDS polyacrylamide gel. The proteins revealed 
by this analysis included all three components of the MRE11/RAD50/NBS1 (MRN) complex, a 
nuclease that functions in many aspects of DNA metabolism including DNA DSBs. To confirm 
this finding, the RECQ5 immunoprecipitate from 293T cells was subjected to Western blot 
analysis using antibodies against the individual MRN subunits. We found that this 
immunoprecipitate contained a large fraction of the endogenous MRN proteins, whereas the 
control immunoprecipitate obtained with IgG isolated from a pre-immune rabbit serum was devoid 
of these proteins (Figure 1A, compare lanes 1-3). The concentration of MRN proteins in the 
RECQ5 immunoprecipitate did not significantly change if the cell extract was pre-treated with 
DNaseI or ethidium bromide, indicating that the association of RECQ5 with the MRN proteins is 
not mediated through independent DNA binding (Figure 1A; compare lanes 3, 4 and 5). We also 
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performed a reciprocal co-immunoprecipitation experiment using anti-MRE11 antibody. In 
agreement with the above data, we found that MRE11 immunoprecipitate contained a significant 
amount of the RECQ5 protein in addition to RAD50 and NBS1 (Figure 1B). Collectively, these 
data indicate that a fraction of MRN proteins exist as a stable complex with RECQ5 in vivo. 
 Next, we compared the levels of the MRE11 protein in RECQ5 immunoprecipitates from 
cells exposed to various genotoxic agents including hydroxyurea (HU), ionizing radiation (IR) and 
cisplatin in order to evaluate the effect of DNA damage on the formation of the RECQ5/MRN 
complex in vivo. The data from this experiment indicated that the cellular level of the 
RECQ5/MRN complex was not affected by exogenously-induced DNA damage except for a small 
reduction after IR (Figure 1C). Moreover, we examined the levels of RECQ5/MRN complex at 
different stages of the cell cycle. To do so, U2OS cells were synchronized at G1/S transition by 
HU treatment and then released into drug-free medium. Cells were collected at different time 
points after the removal of HU and subjected to immunoprecipitation with anti-RECQ5 antibody. 
In a parallel experiment, cell populations from the individual time points were subjected to FACS 
analysis to determine the stage of the cell cycle. We found that the level of the RECQ5/MRE11 
complex remained constant throughout the cell cycle, suggesting a constitutive association (Figure 
1D and Supplementary Figure S1). 
To determine whether RECQ5 interacts with the MRN complex directly, we performed 
affinity pull-down assays with purified recombinant proteins. RECQ5 was expressed in bacteria as 
a fusion with a chitin-binding domain (CBD) and bound to chitin beads. The beads were 
subsequently incubated with recombinant MRN complex produced in insect cells by means of 
baculovirus system. We found that purified MRN complex was avidly bound to RECQ5 beads, but 
not to control beads coated with the E. coli McrA protein fused to CBD (Figure 2A, top panel). 
We also tested the individual MRN subunits as well as the MR complex for binding to RECQ5-
CBD-beads in order to map more closely the interaction site for RECQ5 on the MRN complex. 
We found that except for RAD50, all these proteins were bound to RECQ5, suggesting that the 
interaction of RECQ5 with the MRN complex is mediated by the MRE11 and NBS1 proteins 
(Figure 2A, bottom panel, and 2B). 
To confirm this finding, we performed immunoprecipitation experiments with total protein 
extracts from NBS (NBS1-deficient) and ATLD1 (MRE11-deficient) cells. We found that the 
RECQ5 immunoprecipitate from NBS cells contained both MRE11 and RAD50 proteins in similar 
concentrations as the RECQ5 immunoprecipitate from NBS cells complemented with the NBS1 
cDNA, suggesting that the formation of the RECQ5/MRN complex in the cell does not rely on the 
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interaction between RECQ5 and NBS1 (Figure 2C, lanes 1, 2, 5 and 6). In ATLD1 cells lacking 
MRE11, the levels of NBS1 and RAD50 proteins were dramatically reduced as previously 
reported (34). However, a small amount of NBS1 could be detected in the RECQ5 
immunoprecipitate from these cells, indicating that NBS1 could interact with RECQ5 even in the 
absence of MRE11 inside the cell (Figure 2C, lanes 3, 4, 7 and 8). In ATLD1 cells complemented 
by stable transfection of the MRE11 cDNA, expression of all three MRN proteins could be readily 
detected by Western blot (Figure 2C, lane 4). Accordingly, the RECQ5 immunoprecipitate from 
total extract of these cells was found to contain substantial amounts of all three MRN proteins 
(Figure 2C, lane 8). 
RECQ5 inhibits the 3’ - 5’ exonuclease activity of MRN complex 
Next, we investigated whether the interaction between RECQ5 and the MRN complex affects the 
biochemical activities of these proteins. First we tested the effect of the MRN complex on the 
helicases activity of RECQ5. Previous studies demonstrated that RECQ5 displays a poor helicase 
activity on oligonucleotide-based partial duplexes due to a strong strand-annealing activity 
residing in the C-terminal half of RECQ5 (13). However, RECQ5 could efficiently displace the 
lagging-strand oligonucleotide from synthetic forked structures with homologous arms where re-
annealing of this oligonucleotide is prevented by annealing of the parental strands (17). Thus, we 
evaluated the effect of the MRN complex on this strand-exchange reaction. We found that the rate 
of RECQ5-mediated strand-exchange was not altered upon the addition of the MRN complex, 
suggesting that the MRN complex does not modulate the helicase activity of RECQ5 (Figure 3A). 
The MRN complex was shown to possess a robust 3’-5’ exonuclease activity residing in 
the MRE11 protein (28, 37). We tested the effect of RECQ5 on the MRN-mediated exonucleolytic 
processing of a 30-bp duplex with 30-nucleotide ssDNA tail. Our initial experiments showed that 
the MRN complex (40 nM) required manganese and ATP as cofactors to exhibit efficient 3’-5’ 
exonuclease activity on this DNA substrate (1nM), which is consistent with previously published 
data (data not shown). Addition of increasing concentrations of RECQ5 (0 - 80 nM) to this 
reaction resulted in a gradual decrease in the exonuclease activity of MRN with complete 
inhibition seen at a RECQ5 : MRN ratio of 2 (Figure 3B, lanes 3-7). This effect was not observed 
with the E. coli RecQ helicase, excluding the possibility that the inhibition of the MRE11 nuclease 
by RECQ5 results from competition between these proteins for the DNA substrate (Figure 3C, 
lanes 3-7).  
To investigate whether the inhibition of the exonuclease activity of MRN by RECQ5 is 
dependent on the presence of the NBS1 protein, we evaluated the effect of RECQ5 on the 
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exonuclease activity of the MR complex. The MR complex displayed a similar exonuclease 
activity as the MRN complex (Figure 3 B and C, compare lanes 3). Most importantly, RECQ5, but 
not RecQ, was found to dramatically inhibit the MR-mediated exonucleolytic processing (Figure 
3A and B, lanes 8-12). 
Collectively, these data suggest that RECQ5 negatively regulates the MRN complex by 
attenuating its exonuclease function through direct interaction with the MRE11 protein.  
RECQ5 and the MRN complex co-localize at stalled replication forks and DNA double-
strand breaks 
To explore the role of the RECQ5/MRN complex in the maintenance of genomic stability, we 
analyzed the spatial relationship of these proteins in the nucleus in response to various types of 
DNA damage including stalled replication forks, DNA adducts and DSBs. In these experiments 
we used the human osteosarcoma cell line U2OS. After individual DNA-damaging treatments, cell 
were fixed with methanol and immunofluorescently stained to visualize the cellular distribution of 
RECQ5 and RAD50 proteins by fluorescence microscopy. As expected, in majority of unperturbed 
cells, both RECQ5 and RAD50 were uniformly distributed in the nucleus (Figure 4A). After 
hydroxyurea (HU) treatment that results in replication arrest due to depletion of deoxy-
ribonucleotides, both RECQ5 and RAD50 formed bright nuclear foci that extensively co-localized 
in more than 70% of cells (Figure 4A). RECQ5 and RAD50 also largely co-localized at nuclear 
foci after exposure of cells to UV light (40 J/m2) that can stall the progression of replication forks 
through induction of bulky DNA lesions (Figure 4A). Thus, it is possible that the RECQ5/MRN 
complex operates in the processing of stalled replication forks. 
To generate DSBs, U2OS cells were pre-sensitized by incorporation of BrdU into genomic 
DNA and then locally exposed to UVA light (355 nm) using micro-laser technology, which results 
in linear tracks of DSBs across each irradiated nucleus (21). These tracks can be detected by 
immunofluorescence imaging of phosphorylated histone H2AX (γ-H2AX) that is rapidly 
generated in the DSB-flanking chromatin by the ATM kinase (2). We found that RECQ5 started to 
accumulate at DSB tracks as early as 15 minutes after irradiation, reaching maximal levels at about 
30 minutes after irradiation, and persisted at those sites as long as 1 hour after irradiation (Figure 
4B, top panel). Accumulation of RECQ5 at micro-irradiated areas was seen essentially in all γ-
H2AX-positive cells (150 cells evaluated in two independent experiments), suggesting that the 
recruitment of RECQ5 to DSBs is not restricted to any particular phase of the cell cycle. Most 
importantly, the tracks of RECQ5 detected at 30 minutes after laser microirradiation completely 
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co-localized with the tracks of RAD50 protein, suggesting that the RECQ5/MRN complex plays a 
role in the cellular response to DSBs (Figure 4B, bottom panel) 
The MRN complex is required for the recruitment of RECQ5 to sites of DNA damage 
As the MRN complex is well known to function as a DNA damage sensor, we tested the 
possibility that it mediates the recruitment of RECQ5 to sites of DNA damage. First, we evaluated 
the effect of MRE11 deficiency on the focal distribution of RECQ5 after HU treatment. To do so, 
we silenced the expression of the MRE11 gene in U2OS cells using two different shRNA 
constructs. With both constructs, we observed a dramatic reduction in the cellular level of MRE11 
protein following puromycin selection for clones expressing shRNA, whereas no reduction in 
MRE11 levels was observed in cells harboring a control construct expressing a scrabbled shRNA 
(Figure 5A). Depletion of MRE11 by shRNA also dramatically reduced the cellular level of 
RAD50, which is consistent with low levels of RAD50 found in ATLD1 cells (compare Figure 
5A, lane 2 and Figure 2C, lane 3). Importantly, we found that shRNA-mediated depletion of 
MRE11 in U2OS cells completely abolished the formation of RECQ5 foci in response to HU 
(Figure 5B, left panel). In contrast, U2OS cells expressing the control shRNA contained both 
RECQ5 and RAD50 foci that showed extensive co-localization (Figure 5B, right panel). 
Essentially the same results were obtained with ATLD1 and ATLD1-MRE11 cells (Figure 5C). 
 Further, the MRE11-proficient and deficient cells were doubly stained for RECQ5 and γ-
H2AX. Histone H2AX is phosphorylated in response to replication arrest in ATR-dependent 
manner and forms nuclear foci that colocalize with PCNA and hence can serve as markers for 
stalled replication forks. (20, 38). As expected, in MRE11-proficient cells treated with HU, 
RECQ5 extensively co-localized with γ-H2AX at bright nuclear foci (Figure 5B and C, right 
panels). MRE11-deficient cells also displayed γ-H2AX foci in response to HU treatment (Figure 
5B and C, left panels). However, RECQ5 foci co-localizing with γ-H2AX foci were not seen in 
these cells (Figure 5B and C, left panels). 
To evaluate whether MRE11 is required for the recruitment of RECQ5 to DSBs, we 
microirradiated ATLD1 cells with UVA laser and stained them for RECQ5 and γ-H2AX at 30 
minutes after irradiation. Interestingly, γ-H2AX tracks were detected only in a subset of irradiated 
ATLD1 cells. However, accumulation of RECQ5 at irradiated areas was not seen in any of these 
cells (Figure 6, top panel). In contrast, in ATLD-MRE11 cells, γ-H2AX and RECQ5 tracks were 
seen in all irradiated cells as in the case of U2OS cells (Figure 6; top panel). Moreover, co-
localization of RECQ5 and RAD50 at laser-induced damage could also be detected in ATLD1-
MRE11 cells (Figure 6, bottom panel). 
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Together, these data strongly suggested that MRE11 is required for the recruitment of RECQ5 to 
stalled replication forks and DSBs. 
 
DISCUSSION 
In this work, we present several lines of evidence suggesting a functional link between the human 
RECQ5 helicase and the MRN complex that plays a central role in many aspects of DNA 
metabolism involving DSBs. We found that these proteins formed a stable complex in vivo and in 
vitro through direct binding of RECQ5 to MRE11 and NBS1. At the biochemical level, RECQ5 
strongly inhibited the 3’-5’ exonuclease activity associated with the MRE11 protein, suggesting 
that RECQ5 interacts with the nuclease domain of MRE11 and hence prevents its access to the 
DNA substrate. At the cellular level, MRE11 was required for the accumulation of RECQ5 at sites 
of arrested replication forks and sites of laser-induced DSBs. Base on these findings, we propose 
that the MRN complex recruits RECQ5 to site of DNA damage and that these proteins work 
together to maintain genome stability. 
 Several lines of evidence suggest that the MRN complex promotes genomic integrity 
during DNA replication. The MRN complex is associated with replicating DNA throughout S-
phase through its interaction with replication protein A, which is dependent on phosphorylation of 
both proteins by cyclin-dependent kinases (23, 25, 26). Depletion of MRN in Xenopus egg extracts 
results in accumulation DSBs during chromosomal DNA replication and a failure in restarting 
collapsed replication forks (6, 36). Moreover, it has been demonstrated that MRN is present in 
close proximity of restarting forks and that its relocalization to restarting forks is driven by 
ATR/ATM dependent phosphorylation (6, 36). These findings led to a model in which MRN, via 
its DNA tethering activity, promotes recapture of the broken DNA molecules at collapsed forks, 
favoring the reassembly of new functional forks through DNA recombination events (6, 36). 
Evidence also suggest that MRN acts in conjunction with CtIP to mediated resection of DSBs at 
collapsed forks to generate 3’-ssDNA tails for HR repair (30).  Mouse Recql5-deficient cells 
accumulate RAD51/γ-H2AX foci in S-phase, which is clearly evident upon treatment of cells with 
camptothecin, a potent S-phase specific DSB inducer (16). Thus, it appears that also RECQ5 plays 
a role in the repair of collapsed replication forks, possibly as a part of the MRN complex. Our 
observation of rapid MRN-dependent accumulation of RECQ5 at laser-induced DSBs is consistent 
with this assumption. We have previously shown that RECQ5 could displace RAD51 from single-
stranded (ss)DNA in a manner dependent on its ATPase activity (16). Moreover, RECQ5 
deficiency was found to be associated with a significant increase in the level of DSB induced HR 
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(16). Therefore, RECQ5 could regulate HR repair at collapsed forks by preventing spurious HR 
events. It is also possible that RECQ5 prevents formation of RAD51 filaments on ssDNA regions 
at stalled forks that would hamper replication restart. In agreement with the later scenario, our 
preliminary experiments indicated that mouse recql5-/- cells are hypersensitive to hydroxyurea and 
aphidicolin that cause replication arrest (unpublished observations). 
 Previous studies demonstrated that other human RecQ helicases, namely BLM and WRN, 
are also linked functionally to the MRN complex. BLM was shown to be specifically required for 
the correct re-localization of the MRN complex at sites of replication arrest (11). As in the case of 
RECQ5, the re-localization of WRN to arrested replication forks and γ-radiation-induced DSBs 
requires a functional MRN complex (5, 12). WRN also forms a complex with MRN both in vivo 
and in vitro. However, WRN and RECQ5 differ in the nature of their interaction with MRN. WRN 
and MRN form a complex in vivo only in response to DNA damage or replication arrest (5, 12). In 
contrast, RECQ5 appears to associate with MRN constitutively in vivo. The interaction between 
WRN and the MRN complex is solely mediated by NBS1 (5), while RECQ5 can bind to both 
MRE11 and NBS1, and the absence of NBS1 does not affect the association of RECQ5 with the 
MR complex. At the functional level, MRN dramatically stimulates the helicase activity of WRN 
(5), whereas it has no effect on the helicase activity of RECQ5. Further studies will be needed to 
fully understand the molecular mechanisms by which the RecQ helicases and MRN proteins work 
together to maintain genomic stability. 
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FIGURE LEGENDS 
 
Figure 1. RECQ5 and MRN proteins form a complex in vivo. (A) Co-immunoprecipitation of the 
MRE11, RAD50 and NBS1 proteins with RECQ5 from a total extract of exponentially growing 
HEK293T cells (1 mg of protein). Lane 1, 5% of the input material; lane 2, immunoprecipitation 
using IgG (2 µg) isolated form a preimmune serum; lane 3, immunoprecipitation with affinity-
purified rabbit anti-RECQ5 antibody (1 µg); lane 4, the same as lane 3, but the extract was 
pretreated with DNase I (50 U) for 30 minutes at 25°C; lane 5, the same as lane 3, but extract was 
supplemented with ethidium bromide (50 µg/ml). (B) Co-immunoprecipitation of RECQ5 with the 
MRE11 protein from total extract of HeLa cells. Lane 1, 5% of the input material; lane 2, 
immunoprecipitation using IgG (2 µg) isolated form a preimmune serum; lane 3, 
immunoprecipitation using mouse monoclonal anti-MRE11 antibody. (C) Effect of various 
genotoxic agents on the cellular association of RECQ5 with the MRN complex. RECQ5 
immunoprecipitates from treated and untreated U2OS cells were subjected to Western blot 
analysis to determine the level of co-precipitated MRE11 protein. NT, non-treated cells; HU, cells 
treated with 2 mM hydroxyurea for 16 hours; IR, cells exposed to ionizing radiation (20 Gy) 
followed by incubation for 12 hours; CDDP, cells treated with 20 µM cis-
diamminedichloroplatinum for 8 hours. (A-C) Immunoprecipitated proteins were separated by 
electrophoresis through 7.5 % (w/v) SDS-polyacrylamide gel followed by Western blotting. 
RECQ5 and MRN proteins were detected using antibodies described in Materials and Methods.  
 
Figure 2. RECQ5 interacts with the MRN complex directly via its MRE11 and NBS1 subunits. 
(A) Binding of the MRN (top panel) and MR (bottom panel) complexes to chitin bead coated with 
RECQ5-CBD fusion. (B) Binding of individually purified RAD50 (top panel), NBS1 (middle 
panel) and MRE11 (bottom panel) proteins to chitin bead coated with RECQ5-CBD fusion. For 
(A) and (B): lanes 1, 30% of input material; lane 2, chitin beads coated with McrA-CBD; lane 3, 
chitin beads coated with RECQ5-CBD fusion protein (C) Western-blot analysis of RECQ5 
immunoprecipitates from total extracts (1 mg of protein) of the following cells: NBS (NBS1 
deficiency), NBS1+ (NBS complemented by stable transfection of the NBS1 cDNA), ATLD1 
(MRE11 deficiency) and ATLD+ (ATLD complemented by stable transfection of the MRE11 
cDNA). Lanes 1-4, 5% of the input material as indicated, lanes 5-8, RECQ5 immunoprecipitates 
from total extracts (1 mg of protein) of the indicated cells. Blots were probed for the presence of 
MRE11, RAD50 and NBS1 using antibodies described in Materials and Methods. 
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Figure 3. RECQ5 inhibits the 3’-5’ exonuclease activity of MRE11. (A) Effect of the MRN 
complex on the strand-exchange activity of RECQ5 on a synthetic forked DNA structure with 
homologous arms lacking the leading strand. Top panel: Scheme of the assay. The lengths of the 
oligonucleotide substrate are indicated (nt, nucleotides; bp, base pairs). The 3’-end of the lagging 
oligonucleotide is indicated by an arrow and the position of the 5’-32P label is marked by an 
asterisk. The homologous leading and lagging arms have a 5-nt heterology at the fork junction to 
prevent spontaneous strand exchange. Bottom panel: 1 nM 32P-labeled 30-mer/60-mer duplex was 
incubated with 1 nM 60-mer complementary oligonucleotide in the presence of 40 nM RECQ5 to 
form forked DNA structure. After 10 minutes, ATP (2 mM) was added either alone (lanes 2-9) or 
together with the MRN complex (40 nM) (lanes 2 - 9). Aliquots from different reaction time points 
were analyzed by non-denaturing PAGE followed by phosphorimaging. Lanes 1 (marked by C), 
the 30-mer/60-mer duplex prior to annealing of the complementary oligonucleotide. (B) Effect of 
RECQ5 on the 3’-5’ exonuclease activity of MRN (lanes 3 to 7) and MR (lanes 8 to 12). (C) Effect 
of E.coli RecQ on the 3’-5’ exonuclease activity of MRN (lanes 3 to 7) and MR (lanes 8 to 12). In 
(B) and (C), reaction mixtures were incubated at 37°C for 30 minutes, and contained 1 nM 5’-
tailed oligoduplex substrates (60-mer/30-mer with a 5’-32P label on the shorter strand), 40 nM 
MRN or MR and various concentrations of RECQ5 or RecQ as indicated. Reaction products were 
analyzed by denaturing PAGE followed by phosphorimaging as described in Materials and 
Methods.  
 
Figure 4. RECQ5 and RAD50 co-localize at sites of DNA damage. (A) Indirect 
immunofluorescence imaging of RECQ5 and RAD50 in U2OS cells prior to and after DNA 
replication arrest. Cells were either left untreated or incubated in the presence of hydroxyurea 
(HU) for 16 hours or exposed to UV light at a dose of 40 J/m2 followed by incubation for 6 hours. 
After treatment, cells were fixed with methanol and triply stained for RECQ5 (green), RAD50 
(red) and DNA (blue) as described in Materials and Methods. Images were captured by an 
Olympus IX81 fluorescence microscope. Overlap between the green and red signals in merged 
images appears yellow. (B) RECQ5 and RAD50 accumulate at laser-induced DNA double-strand 
breaks (DSBs). U2OS cells were sensitized with BrdU (10 µM; incubation for 24 hours) and 
subjected to microirradiation with pulsed UVA laser (λ=355 nm) to generate linear tracks of 
DSBs. At indicated time points after irradiation, cells were fixed with methanol and co-
immunostained either with anti-RECQ5 (green) and anti-γ-H2AX (red) antibodies or with anti-
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RECQ5 (green) and anti-RAD50 (red) antibodies as indicated. DAPI (blue) was used to stain 
nuclei. Images were captured and processed as in (A). 
 
Figure 5. MRE11 is required for the recruitment of RECQ5 to stalled replication forks. (A) 
Western blot analysis of extracts of U2OS cells expressing indicated shRNAs. Cells were 
transfected with appropriate shRNA vector and subjected to puromycin selection for 3 days to 
enrich the population of transfected cells. Blots were probed for MRE11, RAD50, RECQ5, 
RAD51, ATM and TFIIH (loading control) using antibodies described in Materials and Methods. 
Lane 1, extract from cells expressing control shRNA (shRNActrl), lane 2 and 3, extracts from cells 
expressing shRNA#1 and shRNA#2, respectively, targeting different sequences of MRE11. (B) 
Effect of shRNA-mediated depletion of MRE11 in U2OS on nuclear distribution of RECQ5 in 
response to HU. Cells were transfected either with the plasmid expressing shRNActrl (right panel) 
or the plasmid expressing shRNA#1 (left panel), followed by puromycin selection. Two days after 
addition of puromycin, HU was added to a final concentration of 2 mM. After 16 hours, cells were 
fixed and co-immunostained either for RECQ5 (green) and RAD50 (red) [top row] or for RECQ5 
(green) and γ−H2AX (red) [bottom row]. Images were captured and processed as in Figure 4. (C) 
Nuclear distribution of RECQ5 in ATLD1 (MRE11 deficient) [left panel] and ATLD1-MRE11 
(complemented by stable transfection of the MRE11 cDNA) [right panel] cells after replication 
arrest by HU. Exponentially growing cells were treated with 2 mM HU for 16 hours and then fixed 
and co-stained either for RECQ5 (green) and RAD50 (red) [top row] or for RECQ5 (green) and 
γ−H2AX (red) [bottom row]. Images were captured and processed as in Figure 4. 
 
Figure 6. MRE11 is required for the recruitment of RECQ5 to DNA DSBs. BrdU-sensitized 
ATLD1 and ATLD1-MRE11 cells were irradiated with UV-A laser, fixed at 30 minutes after the 
irradiation and co-immunostained to visualize either RECQ5 (green) and γ−H2AX (red) [top and 
middle panel] or RECQ5 (green) and RAD50 (red) [bottom panel]. DAPI (blue) was used to stain 
nuclei. Images were captured and processed as in Figure 4. 
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SUPPLEMENTARY INFORMATION 
 
Supplementary Figure S1. Cell cycle status has no significant influence on the cellular level of 
RECQ5/MRN complex. (A) U2OS cells were synchronized at G1/S transition by treatment with 
hydroxyurea (HU) for 16 hours and then released to S phase by adding fresh medium without HU. 
At indicated time points, the level of RECQ5/MRN complex was analysed by 
immunoprecipitation under conditions described in the legend of Figure 1. (B) FACS analysis. The 
resultant cell cycle profiles for each time point (T0-9) are shown. AS, asynchronous cell 
population 
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7.4.  Appendix IV: Physical and functional interactions between Werner 
syndrome helicase and mismatch-repair initiation factors
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